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PRENATAL SUBSTANCE MISUSE:  EXPLORING HEALTHCARE  
PROVIDERS’ ATTITUDES AND PERCEPTIONS 
To maximize beneficial outcomes for babies and mothers in substance misuse 
situations, it is necessary to understand the current societal factors and the stigma that 
healthcare providers may be imposing on the families.  More than 5% of all pregnancies 
are affected by prenatal substance misuse prompting a public health crisis.  The negative 
effects from drug misuse on the growing baby ranges from neonatal abstinence syndrome 
(NAS), mental retardation, behavioral abnormalities, and neurological deficits.  The 
exposure also causes lengthy hospitalizations for babies and high financial costs.  The 
provider must balance their own feelings and beliefs about substance misuse in 
pregnancy while simultaneously providing appropriate and supportive care to the mother.  
However, health-related stigma can occur as providers must care for both mother and 
baby, in an often stressful work environment.   
 This research explored structural stigma, which broadly encompassed the policies 
and cultural practices, towards women with prenatal substance misuse among providers 
in a maternal/fetal healthcare unit. The study, with 117 participants from an area hospital 
system, examined several variables including the attitudes, perceptions, and stigma 
among healthcare providers towards prenatal substance misuse.  A factorial MANOVA 
and descriptive analysis was used to assess the data.  Among the findings, a significant 
difference was found between the type of employment discipline and a practitioner’s 
attitudes and level of structural sigma.  Direct Care Nurses had an increased negative 
attitude towards women with prenatal substance misuse.  Additionally, there was a strong 
viii 
correlation (r=0.612) between the cause of substance misuse and a healthcare provider’s 
attitudes towards prenatal substance misuse.  If the provider believed substance misuse 
stemmed from a moral flaw or failing, he/she had a more negative attitude towards 
women with prenatal substance misuse.  The current study identified the potential stigma 
and attitudes among healthcare providers and offered insight into the practice methods 
within the healthcare setting.  Specifically, a three-tiered protocol to improve the culture, 
education, and practice within the hospital setting emerged.  
 
Robert Vernon, Ph.D., Chair  
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Chapter One:  Prenatal Substance Misuse:  Exploring Health  
Care Providers’ Attitudes and Perceptions  
Introduction 
Prenatal substance misuse is a public health concern (Stone, 2015) with more than 
5% of all pregnancies resulting in illicit prenatal substance exposure (NIDA, 2017).  
However, the incidence of prenatal substance misuse may be substantially higher as drug 
misuse is often underreported when not using biomarkers (Chiandetti et al., 2017; Garg et 
al., 2016).  Substance misuse crosses all racial, class, and age demographics though 
differences lie in the type of substance used (Prasad, 2014; Stein, 2002).  However, all 
have negative effects on the growing fetus ranging from neonatal abstinence syndrome 
(NAS), mental retardation, behavioral abnormalities, and neurological deficits (Logan, 
Brown, & Hayes, 2013; Patrick et al., 2012; Stein, 2002).  Prenatal substance misuse 
causes not only lengthy hospitalizations for both mother and baby but high financial costs 
for the taxpayer (Patrick et al., 2012; Whiteman et al., 2014).   
The compounding effects of drug use and fetal distress can make it difficult for 
providers to remain positive or even neutral toward the mother.  Thus, provider beliefs 
regarding drug use may lead to stigma.  Health-related stigma is a “sociocultural process 
in which social groups are devalued, rejected, and excluded on the basis of a socially 
discredited health condition” (Livingston, Milne, Fang, & Amri, 2012, p. 39).  An 
individual with addiction can face varying degrees of negative interactions.  Medical 
providers may under-medicate patients with substance misuse due to concerns of drug-
seeking behavior or negative feelings towards the individual (Stein, 2002).  Parental 
support is a leading tool to increase positive outcomes for drug-exposed infants (Seattle 
Children’s, nd.).  If, however, the mother is met with judgment, anger, or dismissiveness, 
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she will likely have poor follow-up care and limited hospital visitation with her baby.  
This situation may negatively affect the mother’s progress in bonding with the baby and 
lead to more negative outcomes for the baby.  To maximize beneficial outcomes for 
babies in substance misuse situations, it is necessary to understand the current societal 
facts, the varying types of drug situations, the cross racial/economic status nature of drug 
misuse, the varying legal implications, and the stigma that healthcare providers may, 
intentionally or unintentionally, be imposing on these families.  Once providers recognize 
their part in the imposed stigma, they may be willing to take action to enhance the 
opportunities for a more positive health situation for mother and baby, as well as an 
improved work environment.   
Opioid explosion.  In 2012, more than 21,000 babies born in the United States 
experienced opioid withdrawal (National Institute on Drug Abuse, 2017).  The instance 
of opioid dependent babies has grown fivefold since 2000 (National Institute on Drug 
Abuse, 2017).  On August 10, 2017, President Trump declared the opioid crisis a national 
emergency.  The opioid crisis not only affects the substance user but also her unborn 
baby.  Although pregnancy can act as a leading factor for pregnant women to seek 
addiction assistance, 5% still report substance misuse during pregnancy (National 
Institute on Drug Abuse, 2017; Patrick et al., 2012).  Every hour of every day, a baby is 
born with Neonatal Abstinence Syndrome or NAS (Patrick et al., 2012).  Although the 
2012 study by Patrick et al. calculated 5.63 per 1000 pregnant women are diagnosed with 
opiate use/dependence at the time of delivery, this does not account for other substances 
like methamphetamines, benzodiazepines, cocaine, marijuana, and alcohol, which also 
cross the placenta and negatively affect the baby.  The opioid crisis has severely affected 
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women of reproductive age (Logan et al., 2013), as females 15-25 have higher reported 
opioid misuse (Smith & Lipari, 2017).  Opioids are the second most used substance in 
pregnancy following marijuana (Forray, 2016; Logan et al., 2013; McCabe & Arndt, 
2012). 
Financial implications.  In 2009, the financial cost to care for babies with NAS, 
after adjusting for inflation, rose to $720 million (Patrick et al., 2012).  Medicaid is the 
primary payer as both mother and baby have a higher percentage of active Medicaid 
coverage (Jacobson et al., 1991; Patrick et al., 2012; Whiteman et al., 2014), which was 
81% in 2012 (National Institute on Drug Abuse, 2017).  The high financial costs for 
drug-exposed babies is due to lengthy hospital stays, roughly 16.3 days versus 3.3 days 
for non-exposed babies, and the need for intensive care services due to complications of 
NAS (Patrick et al. 2012).  Drug-exposed babies may require several months in the NICU 
prior to discharge. 
Health implications.  The health concerns are not only for the growing baby but 
also for the mothers who have higher rates of HIV, Hepatitis B and C, and sexually 
transmitted infections (Chasnoff, Burns, & Burns, 1987; Stein, 2002).  These risks are 
due to the type of drug use and to poor healthcare.  These mothers are also more 
susceptible to sexual assault and violence (D’Apolito, 2014; Stein, 2002), as well as 
malnourishment, due to poor eating habits and limited access to appropriate nutrients 
(Little et al., 2005; Roberts & Pies, 2010; Whiteman et al., 2014).  The aforementioned 
negative health implications affect both mother and baby and could lead to additional 
health crises during and after delivery for both individuals.  
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Unfortunately, only 11% of all individuals with addiction receive treatment at a 
specialty facility (NIDA, 2011).  A barrier to treatment for the substance misuse lies in 
the difficulty of entering treatment programs due to high cost, lack of childcare, dual 
mental health and general medical diagnosis, and lack of services (Jackson & Shannon, 
2011; Stein, 2002).  Despite the development of the Affordable Care Act (ACA), which 
increased some state Medicaid coverage for substance misuse treatment, many states still 
do not offer comprehensive services (Boozang, Bachrach, & Detty, 2014).  The 
Substance Abuse and Mental Health Services Administration (SAMHSA) offers state-
funded services through block grants for pregnant women with substance misuse (Knopf, 
2016).  However, the demand for services far exceeds the available supply (Knopf, 
2016).  SAMHSA requested a 25% increase in funding from Congress for the 2017 fiscal 
year to help increase program availability for pregnant women (Knopf, 2016).  However, 
with still such limited availability for individuals without a payer source, many 
individuals go without the needed care and ongoing support required in combating 
addiction.  A vicious cycle of self-medicating often ensues, which continues drug 
dependence. 
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Chapter Two:  Literature Review 
Neonatal Abstinence Syndrome (NAS) 
There are two forms of NAS:  Iatrogenic NAS which is withdrawal caused by 
medical need (Patrick et al., 2012) and congenital NAS.  Iatrogenic NAS can occur as a 
result of surgeries, heart complications, brain bleeds, necrotizing enterocolitis (NEC), etc.  
The medications are legally prescribed due to other medical concerns and Iatrogenic NAS 
becomes a byproduct.  Iatrogenic NAS cases are not considered in this research as this 
research will focus on prenatal substance misuse.  Congenital NAS is conceptually 
defined for this research as any adverse outcomes of intrauterine substance exposure of a 
baby (Atwell et al., 2016). 
A baby exposed prenatally to illicit drugs may have different responses and 
varying levels of distress.  To this end, a likely higher percentage of women are 
diagnosed with opioid dependence versus babies diagnosed with NAS (Patrick et al., 
2012).  NAS is a medical diagnosis, under ICD-10-CM  P96.1, and requires the presence 
of certain symptoms before a diagnosis is made.  The Finnegan Score, a tool used to 
capture NAS symptoms, is obtained to quantify the baby’s level of drug exposure 
(Busenbark, 2016).  If a baby is drug-exposed and does not show signs or symptoms, the 
baby will not be given a diagnosis of NAS.  Thus, it is likely that the number of 
substance-exposed babies may be underreported.   
Typically, NAS symptoms will manifest within three days post-delivery though, 
in some cases, the symptoms may not surface for seven days (Bhuvaneswar, Chang, 
Epstein, & Stern, 2008; Church, n.d.; Logan et al., 2013).  However, prematurity may 
mask the signs of NAS as the baby will have developmental immaturity and standard 
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NAS scales are invalid with premature babies (Busenbark, 2016; Dryden, Young, 
Hepburn, & Mactier, 2009).  Once symptoms present, the length of symptoms may last 
anywhere from one week to six months (Church, n.d).  The timeframe is dependent upon 
the baby’s reaction to treatment, both pharmacological and non-pharmacological, as well 
as level or type of exposure. Babies exposed to polysubstance use generally have 
increased symptoms such as increased muscle tone, irritability, overall higher Finnegan 
Scores, and longer hospitalization (Dryden et al., 2009; Logan et al., 2013).  To test for 
drug exposure the standard measures are urine, meconium, and hair; however, some 
hospitals use cord blood testing (Benke & Smith, 2013, Bhuvaneswar et al., 2008).  Cord 
blood allows for collection of samples up to seven days after birth.  The testing can also 
monitor for alcohol exposure.  Drug testing is not necessarily mandated across states 
(Bhuvaneswar, et al., 2008).  In Indiana, drug testing may be triggered by late 
presentation to prenatal care, infrequent prenatal care, delivery outside of the 
hospital/homebirth, and admission of drug use/history (Labor of Love Summit, n.d.).  
However, other states, like Ohio, participate in universal screening where all mothers are 
tested upon admission to the hospital (Newman, 2016).  If a mother refuses to be tested, 
her newborn is automatically screened (Newman, 2016).  
Health Complications 
Babies with prenatal drug exposure face a myriad of potential ramifications 
relating to their growth, behavior, cognitive functioning, language, and general 
achievement (Logan et al., 2013; Patrick et al., 2012; Stein, 2002).  They also face an 
increased likelihood of their own substance misuse in adulthood (Church, n.d.).  
However, the effects can depend greatly on the type of drug exposure, the frequency of 
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maternal use, the gestational point of use, and environmental factors (Church, n.d.).  The 
short-term effects are well-documented though long-term outcomes are difficult to 
document due to co-occurring factors like environment (Logan et al., 2013; Seattle 
Children’s, n.d).  Such environmental factors include housing instability (Little et al., 
2005), foster care, and mistrust of healthcare providers (Seattle Children’s, n.d).   
Opioid.  Types of drug exposure also affect the type of complications the mother 
and baby may experience.  Opioid use, including methadone and heroin, often require 
pharmacological assistance to treat the withdrawal symptoms for both the mother and 
baby as detoxification can be lethal (Stein, 2002; Sun, 2004).  The mother is at-risk for 
placenta abruption, which is when the placenta detaches from the uterus; eclampsia or 
extreme high blood pressure; sexually transmitted infection; preterm labor/delivery; and 
Hepatitis A, B, and C (Little et al., 2005; Sun, 2004).  All of these maternal health 
complications can affect the baby.  The symptoms of opioid use in a baby, which can last 
from a few days to weeks, include hypertonia or muscles appearing stiff or rigid, 
irritability and being difficult to console, sneezing, excessive sucking or poor sucking 
ability which leads to poor feeding, and an intense high-pitched cry (Hudak & Tan, 2012; 
Lester, Tronick, & Seifer, 2002).  On average, opioid-exposed babies have physical 
effects like lower birth weight and length and smaller head circumference (Logan et al., 
2013).  Opioid use also can lead to premature birth which incorporates a host of 
additional complications.  Babies who are born premature due to opioid exposure may 
have apnea and increased susceptibility for Sudden Infant Death Syndrome (SIDS) 
(Chasnoff et al., 1987).  Long-term effects, while difficult to quantify, include poor 
cognitive, perceptual, and memory skills (Seattle Children’s, n.d.) 
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Methadone. Methadone is an opiate replacement therapy used to help manage 
withdrawal from opioids (Alaedini, Haddadi, & Asadian, 2017; Bhuvaneswar et al., 
2008; Dryden et al., 2009; Logan et al., 2013).  Methadone does cross into the placenta 
which will lead to withdrawal similar to opioid use (Logan et al., 2013).  However, when 
methadone is administered as an opiate replacement therapy, it is in a controlled 
environment.  Withdrawal from opiates can cause fetal death (Logan et al., 2013; Sun, 
2004).  Thus, women seeking assistance during pregnancy for opioid addiction may be 
placed on methadone (Logan et al., 2013; Prasad, 2014; Sun, 2004).  Methadone 
withdrawal has similar effects on the baby as stated above with long-term effects noted of 
lower IQ scores; poor coordination; hyperactivity; and poor memory, verbal, and 
perceptual skills (Church, n.d.; Seattle Children’s, n.d.) 
Similar to methadone is buprenorphine.  Buprenorphine also acts as an opiate 
replacement though it allows for the women to self-administer the dose and decreases the 
need for daily outpatient visits to methadone clinics (Patrick et al., 2013).  
Buprenorphine, also known as Suboxone and Subutex, lessens the financial burden for 
the healthcare industry as daily visits are not necessary (Patrick et al., 2013).  Though 
harm reduction allows for greater mother and baby well-being (Stein, 2002), there is 
limited data to determine the long-term effects of opiate replacement therapies (Church, 
n.d.; Logan et al., 2013).  Buprenorphine is not without risk and has been linked to 
increased hyperactivity, poor memory function, and NAS (Seattle Children’s, n.d; Stein, 
2002).  Treatment programs such as methadone and buprenorphine also cause NAS and 
potential long-term problems, though such programs may increase lifestyle stability, 
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decrease potential intrauterine growth restriction, prematurity, and decrease maternal and 
fetal mortality (Dryden et al., 2009; Prasad, 2014; Stein, 2002; Worley, 2014). 
Cocaine.  Cocaine use during pregnancy is linked to increased incidence of 
vascular accidents, Intra Uterine Growth Restriction (IUGR), maternal hemorrhage, 
central nervous system infarction, and placenta abruption (Chasnoff, et al., 1987; Stein, 
2002).  After the birth, behavioral and language abnormalities can occur (Church, n.d.).  
Studies indicate that babies prenatally exposed to cocaine have a higher rate of SIDS 
(Chasnoff et al., 1987).  
Alcohol. Alcohol use has shown drastic negative effects on behavior, cognition, 
language, and achievement of prenatally-exposed babies (Church, n.d.).  Fetal alcohol 
syndrome includes craniofacial abnormalities and neurodevelopment delays (Logan et al., 
2013; Stein, 2002).  Mental retardation can also occur (Stein, 2002).  Approximately 10-
20% of childhood mental retardation is caused by prenatal alcohol exposure (Stein, 
2002). 
Marijuana.  Marijuana is the leading type of prenatal drug exposure (Forray, 
2016; Logan et al., 2013; McCabe & Arndt, 2012), with approximately 1 in 25 women 
self-reporting marijuana use during pregnancy (Ko et al., 2015).  The actual use of 
marijuana and general drug misuse during pregnancy may be higher due to limitations in 
recall and patient answer bias (Benhke & Smith, 2013; Garg et al., 2016).  Marijuana has 
been adversely linked to behavioral, cognitive, and achievement delays (Church, n.d.).  
The growing legalization of marijuana may impact the already high use of marijuana in 
pregnancy. 
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Long-Term Health Implications 
The long-term effects of drug-exposure for babies are difficult to measure as 
babies who experience NAS often also experience environmental factors that negatively 
affect their development.  Drug-exposed babies have higher instances of foster care, 
family instability, and chronic family stress (Seattle Children’s, n.d.).  The families often 
have a mistrust of the healthcare system which may deter parents from participating in 
programs for their baby, again adversely affecting development (Seattle Children’s, n.d.).  
The relationship between providers and mothers influences the success of follow-up care, 
trust, and early intervention (Howell & Chasnoff, 1999).   
Treatment Options 
The treatment necessary for a baby experiencing NAS can be affected by maternal 
polysubstance misuse, gestational age at delivery, genetic factors, maternal breastfeeding, 
and caregiver involvement such as rooming-in (Logan et al., 2013; McQueen & Murphy-
Oikonen, 2016).  The two overall types of treatment are pharmacological and non-
pharmacological.  If a baby requires pharmacological treatment, he/she will receive non-
pharmacological treatment as well.  However, some babies are able to be treated solely 
with non-pharmacological approaches like swaddling and a quiet, low stimulus 
environment (McQueen & Murphy-Oikonen, 2016).  Unfortunately, 50-70% of babies 
experiencing NAS will require some form of pharmacological intervention (Logan et al., 
2013). 
Pharmacological support. The Finnegan score assesses for NAS.  If a baby 
scores high on the measure, pharmacological substances like morphine are administered 
to combat physical withdrawal symptoms (Busenbark, 2016).  The Finnegan Score 
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measures withdrawal by severity of the central nervous system disturbances:  muscle 
tone, convulsions, tremors, moro reflex, sleep, and excoriation; metabolic vasomotor/ 
respiratory disturbance:  sweating, hyperthermia, mottling, yawning, sneezing, 
respiratory rate, nasal flaring, and nasal sucking; and gastrointestinal dysfunction:  
excessive sucking, poor feeding, regurgitation, and loose/watery stool (Western 
Australian Centre for Evidence Based Nursing & Midwifery, 2007).  Scoring is 
completed two hours after birth and then in four-hour intervals (Western Australian 
Centre for Evidence Based Nursing & Midwifery, 2007).  If a baby receives two 
consecutive scores above 7, pharmacological protocol is generally initiated (Logan et al., 
2013).  An important distinction is that the test is designed for full-term babies. Thus, it 
can be difficult to quantify NAS in preterm babies born at less than 35 weeks (Goetz, 
n.d.; Western Australian Centre for Evidence Based Nursing & Midwifery, 2007).  
Preterm babies often have a more moderate reaction to drug withdrawal, potentially due 
to less time of drug exposure, limited fat stores, and/or the current ability for staff to 
adequately quantify a preterm baby’s withdrawal (Goetz, n.d.).   
Non-pharmacological support.  Imagine experiencing the worst health condition 
and being forced to lie alone with bright lights and noises ranging from monitor beeps, 
babies crying, and people talking.  Those are just a few of the effects from NAS and 
medication cannot solve all the discomforts.  Non-pharmacological treatments for babies 
experiencing NAS may include such modalities as:  a low stress, quiet environment; skin-
to-skin contact; baby massage; dietary changes; and encouragement of breast feeding 
(Busenbark, 2016; Church, n.d; Dryden et al., 2009).  Babies experiencing NAS often 
have extreme irritability and poor sleep patterns.  A low stimulus environment allows the 
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baby to process through NAS easier (McQueen & Murphy-Oikonen, 2016).  
Additionally, skin-to-skin contact creates a two-fold benefit.  The baby is able to be 
comforted and the parent can begin the bonding process while learning the individual 
needs of the baby (Church, n.d.).  The hospital staff can then assist the mother in 
recognizing the baby’s irritability as a sign of withdrawal rather than the baby rebuffing 
the mother (Sun, 2004).  Some hospitals allow for parental rooming in, which affords the 
parent to have time to bond, interact, and become more fully engaged while the baby 
receives consistent, soothing care (Busenbark, 2016).  Every parent reacts differently to 
their baby’s withdrawal symptoms.  Some parents may feel comfortable reaching out to 
staff for support, others may quietly hide their fear or frustrations, and some may have 
little to no visitation.  By healthcare providers encouraging visitation, teaching skills, and 
allowing the parent to parent, increased bonding and comprehension of the baby’s 
medical needs can occur.   
Parental support.  Beyond the direct care of the baby, parental support is a 
leading tool to increase positive outcomes for drug exposed infants (Seattle Children’s, 
nd.), both in the short- and long-term.  It is important for healthcare providers to 
recognize pregnancy can act as a trigger to increase substance misuse and exacerbate 
existing problems (Crawford, Sias, & Goodwin, 2015).  Ideally, women with substance 
misuse will be followed by a core group of healthcare providers with community workers 
available postpartum (Marangoni & Felix de Oliveria, 2015; Stein, 2002).  Once the 
woman is ready for delivery, however, staff often changes in the inpatient setting and 
continuity of care decreases (Stein, 2002).  Having to rehash the story of one’s drug use 
in a new setting may hinder the progress previously made (Stein, 2002).  The importance 
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of continuity of care includes not only direct medical staff, but ancillary staff as well.  If 
the baby is admitted to the Neonatal Intensive Care Unit (NICU), a separate group of 
providers are often assigned to the baby.  If this is a positive interaction, there may be the 
potential for continued support.  However, if the mother is met with judgment, anger, or 
dismissiveness, the mother’s progress may be negatively impacted and contribute to 
worse outcomes for the baby.  The mother will likely be taking the baby home so it is of 
utmost importance for the mother to visit regularly.  If the mother does not feel welcome 
or accepted, she will likely have a poor visitation pattern. 
New mothers who misuse substances often have increased shame and guilt after 
the baby is born, as they are able to now witness what has occurred to the baby because 
of their actions (Stein, 2002).  Parental emotional support and encouragement of 
mother/baby interaction is imperative (Stein, 2002), as women with drug misuse have 
higher rates of psychiatric disease, including depression and anxiety (Benningfield et al., 
2010).  If the mother does not have positive bonding with the baby, this can result in 
added psychosocial stressors including depression, frustration, guilt, and increased drug 
use (De Bortoli, Coles, & Dolan, 2014; Stein, 2002). 
Drug-exposed babies are far more irritable than the typical newborn (Chasnoff, 
Burns, & Burns, 1987).  Babies with increased irritability are difficult to soothe and lose 
important caregiver attention/affection due to these behaviors (Chasnoff et al., 1987).  
This causes a devastating cycle of isolation and poor bonding for both parties.  The 
baby’s safety is at risk if he/she is discharged to a home where there is little to no 
bonding or the parent is in a state of crisis. As such, the incidence of abuse/neglect is 
tripled in the presence of a drug-misusing parent (Seattle Children’s, n.d). 
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Department of Child Services.  For a baby with prenatal drug-exposure, the 
hospital social worker will file a Child Protective Services report with the Indiana 
Department of Child Services if positive drug screens were present during prenatal care 
or upon admission to the hospital; the baby’s urine, meconium, or cord blood are positive 
for drugs; the baby exhibits withdrawal symptoms; and/or the mother self-discloses drug 
use.  The specific number of reports made each year to the Indiana Department of Child 
Services for prenatal substance exposure was not publicly available.  Indiana DCS 
defines neglect from prenatal drug-exposures as when an “infant is born drug-exposed, as 
indicated by a positive toxicology screen for scheduled drugs or alcohol, symptoms of 
withdrawal, mother’s admission of recent drug use, or other indicators as determined by 
medical personnel” (Children’s Research Center, 2012, p. 8).  The Department of Child 
Services then decides the course of action, which may include such options as out-of-
home placement or in-home services. 
Healthcare providers have a unique opportunity to change the trajectory of a 
woman’s life as pregnancy is a prime motivator for treatment or, at a minimum, 
connecting and building trust within the medical field (Crawford et al., 2015; Marangoni 
& Felix de Olivera, 2015; Stein, 2002).  Pregnant women, despite drug use, more than 
likely will seek healthcare services, even if it is solely for delivery (Stein, 2002).  This 
allows healthcare providers to at least start the process of drug treatment, support, or 
education (Marangoni & Felix de Olivera, 2015; Stein, 2002).  Staff also must support 
women post-partum as care should not end at delivery (Stein, 2002).  However, women 
with Indiana Pregnancy Medicaid often lose their insurance 6 weeks postpartum.  If a 
woman misses her perinatal follow-up appointment, she may not be able to reschedule 
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due to loss of insurance, thus, decreasing the availability of needed support.  This can be 
quite detrimental to a mother experiencing not only substance misuse but also post-
partum depression.  Substance misuse and depression are closely linked and healthcare 
providers must be aware of the added psychosocial stressor and potential of increased 
drug and alcohol use when suffering from post-partum depression (Chapman & Wu, 
2013). 
Barriers to Care 
Women with prenatal drug misuse attend fewer prenatal visits than non-drug 
misusing women (Little et al, 2005; Whiteman, 2014).  The lack of prenatal care among 
pregnant women who use drugs is multifaceted.  Women are generally aware of the 
harmful effects of prenatal drug use, but fear can delay the individual in seeking 
treatment and care (Roberts & Pies, 2010; Stone, 2015).  Roberts and Pies (2010) used 
focus groups and interviews of women with either current prenatal substance misuse or a 
history of misuse.  The interviews yielded a better understanding of the needs and 
barriers to prenatal care.  Such barriers to prenatal care include limited access to health 
insurance, poor transportation, homelessness, feelings that healthcare workers do not 
support or listen to their needs, and fear of Child Protective Services (CPS) involvement 
(Marangoni & Felix de Oliveria, 2015; Roberts & Pies, 2010).  Stone’s (2015) qualitative 
study of 30 women with current prenatal drug and alcohol misuse produced results 
similar to Roberts and Pies (2010) study, though a greater focus on legal implications 
were noted by the women.  Consequently, the fear of criminal prosecution acts as a 
deterrent for prenatal care as women avoid necessary healthcare in hopes of avoiding 
criminal sanctions (Stone, 2015).  Marangoni and Felix de Oliveria’s (2015) exploratory 
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study of 32 hospital case files of prenatal misusing women echoed the results of the 
studies by Roberts and Pies (2010) and Stone (2015).  Women were less likely to adhere 
to prenatal care due to poor socio-economic status, support, and general fear (Marangoni 
& Felix de Oliveria, 2015).  Howell and Chasnoff (1999) noted in the findings from their 
focus group, which included both women who misuse substances and their providers, that 
childcare, fear, limited resource availability, negative provider interactions, and poor 
home life complicates sufficient prenatal care.  Additionally, drug misuse itself is a 
barrier to prenatal care (Roberts & Pies, 2010).  Women report that the act of using can 
be a greater priority over prenatal care (Roberts & Pies, 2010).  Being intoxicated can 
also affect women’s judgment.  For some, increased or continued drug misuse occurs to 
mask the feelings of guilt.  These reactions often lead to decreased prenatal care (Roberts 
& Pies, 2010). 
Insurance.  Pregnancy Medicaid is available to those without insurance and who 
meet the financial requirements.  However, completing the paperwork and obtaining the 
necessary documents can be difficult and confusing.  Homelessness is highly correlated 
with substance misuse (Folsom et al., 2005); thus, the woman may not have a permanent 
address to obtain documents (Roberts & Pies, 2010).  Many providers require proof of 
insurance before scheduling appointments.   
Transportation. Limited transportation is noted as a barrier to prenatal care 
(Crawford, Sias, & Goodwin, 2015).  Although some state Medicaid programs do offer 
transportation assistance to medical appointments, the individual must first have active 
Medicaid and make the appointment three days in advance.  There is also not a guarantee 
that transportation services will be available for the needed time.  Women may have to 
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wait for several hours after the scheduled appointment for pick-up and arrive hours early.  
The individuals must also have a working phone to schedule the appointments.  Many 
resources are now solely online so if an individual does not have access to the Internet, it 
becomes increasingly difficult to reach providers and support (Roberts & Pies, 2010). 
Emotional.  Guilt and fear can also be major barriers to receiving prenatal care 
(Roberts & Pies, 2010; Sun, 2004).  Emotionally, women may shut-down and avoid 
recognizing the pregnancy or become overwhelmed with the process of obtaining care 
and again avoid seeking help (Roberts & Pies, 2010).  Some become isolated (D’Apolito, 
2014) as informing their family or healthcare provider of the pregnancy along with their 
substance misuse may increase fear of rejection (Roberts & Pies, 2010) or prosecution 
(Stone, 2015).  If the woman’s partner is also abusing substances, the woman can be 
forced to choose between her perceived support group and abstinence.  This can be 
isolating if the woman chooses to abstain from drug use or can act as a deterrent to 
prenatal care if the partner is not supportive of treatment (Crawford et al., 2015).  
Additionally, there are high levels of negative self-image and paranoia with the belief that 
everyone knows they are misusing substances.  Such thoughts act as a deterrent to 
seeking care and, when mixed with limited social support, the opportunity for prenatal 
care greatly diminishes (Roberts & Pies, 2010; Sun, 2004).  
Women who are using illicit substances and who attend prenatal check-ups want 
to support their baby as best they can despite the drug use (Roberts & Pies, 2010; Stone, 
2015).  Prenatal care, in part, helps to mitigate the effects of the drug use and decrease 
guilt and anxiety (Roberts & Pies, 2010; Stone, 2015).  Poor prenatal care not only 
decreases the opportunity to support women with maternal/fetal medicine but also 
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decreases services for addiction, mental health, and general health (Prasad, 2014; Roberts 
& Pies, 2010).  Support to help increase prenatal care would include improving the 
Medicaid application process, increasing providers’ willingness to accept patients in their 
third trimester, explaining CPS involvement and ways mothers can improve their 
outcomes, and explaining steps needed to help enhance the health of the exposed baby 
(Roberts & Pies, 2010).  Low self-esteem is also a common characteristic among women 
misusing substances, though positive support from providers can assist in improving a 
person’s self-image (Bowie, 2005; Prasad, 2014; Sun, 2004).  Thus, lack of prenatal care 
is likely not because the person does not care about the baby, but because access to 
resources is complex and because fear and guilt are powerful.  
Implications for Service Providers 
 Working with women who misuse substances during pregnancy can be 
challenging, thus, providers must be educated about best practices for working with 
individuals with drug addiction and their children (Butler, Saunders, & Saunders, 2001; 
Stein, 2002; Worley, 2014).  Such difficulties for the provider may entail ethical concerns 
when mothers are non-compliant with the treatment plan thus increasing potential harm 
to the baby (Stein, 2002).  The complexities of substance misuse are more complicated 
than simple self-indulgence and lack of self-control (Crawford, et al., 2015; Stein, 2002; 
Whiteman, et al.; 2014).  However, negative feelings can manifest in healthcare providers 
when they observe a struggling baby and presumed drug-seeking behaviors of the 
mother.  Bowie’s (2005) study determined abstinence as the main predictor of a mother’s 
ability to successfully parent; however, 40-60% of individuals will relapse (NIDA, 2011).  
Witnessing a parent relapse can be frustrating, devastating, and anger provoking.  
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Providers may feel inadequate as they cannot change a person’s behavior and may 
become emotionally exhausted (Stein, 2002).  Recognizing that the drug addiction is 
relentless and relapse may occur is important (D’Apolito, 2014; Stein, 2002).  Changing 
the mindset from addiction as a crime to addiction as a disease may also help providers 
see the substance misuser as a person with a health condition rather than a junkie 
selfishly harming her baby.    
Such tools as ultrasounds during the prenatal stage can improve the bonding 
between mother and baby (Stein, 2002).  This allows mothers to see their baby.  By 
putting a “face” to the baby, it allows the mother to feel more connected and recognize 
the baby is real.  Whether the mother is using substances, ultrasounds have a way to make 
the pregnancy become more real.  Additionally, building rapport with the woman helps to 
gain trust and ultimately improves providers’ ability to help her (Crawford et al., 2015).  
Healthcare workers need to continually reassess substance use as the relationship builds 
because the mother may become more open over time to discussing concerns (Prasad, 
2014; Stein, 2002).  The focus should be about assistance and support, instead of catching 
them abusing substances.  For example, stigma often lingers for women enrolled in 
methadone and buprenorphine programs (Stein, 2002; Stone, 2015).  In reality, such 
enrollment should be praised and supported as the mother is taking steps towards her own 
health as well as that of her baby (Stein, 2002).  
 Although a provider may be putting forth effort to include the parent, the provider 
may become frustrated or lose empathy for the mother (Stein, 2002).  Such feelings only 
serve to isolate the woman and negatively affect outcomes (D’Apolito, 2014; Stein, 
2002).  Some women report that they would encourage other women not to tell their 
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healthcare providers about their drug use (Howell & Chasnoff, 1999; Stone, 2015).  
However, healthcare workers who offer empathetic and honest care to women have the 
opportunity to provide meaningful care prenatally, at delivery, and post-partum (Stein, 
2002).  By effectively assessing women and their needs, providers can gain greater 
understanding and offer appropriate assistance (Prasad, 2014; Stein, 2002).  What a 
provider believes is the problem (i.e., drug use) may not actually be the greatest concern 
for the mother (Stein, 2002).  However, working with the mother to assist in meeting her 
greatest needs will indirectly assist with decreasing drug use (Stein, 2002).  For example, 
a woman may be more concerned with her living situation than with her drug use.  If 
housing can be improved, she can then work towards new goals, potentially sobriety 
(Stein, 2002).  The goals must be the goals of the individual, not the provider.  By 
bringing the mother into her own treatment plan and allowing her to have a voice, a more 
collective and successful plan can be developed (Crawford et al., 2015; Stone, 2015).  
Each individual has unique strengths and weaknesses, and by capitalizing on the 
individual’s assets, a structured and personal plan can lead to greater success. 
 Providers are challenged to provide care and support to both the mother and baby.  
Undoubtedly, this can be a troublesome and stressful work experience.  Not only is it 
difficult to witness the struggles of the baby, but internally, the professionals themselves 
may struggle if they are facing such things as infertility and child loss.  Transference can 
occur, despite the most professional care provider.  Employer/employee supervision is 
necessary to provide support and decrease potential negative influences of provider 
bias/stigma.  However, simply offering supervision is not adequate as supervision is only 
beneficial if the recipient views the supervisor as supportive (Frimpong, Hellerringer, 
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Awoonor-Williams, Yeji, & Phillips, 2011).  Understanding the ethical and emotional 
challenges is imperative for supportive practice.  
When a provider witnesses the harmful effect of NAS and believes the mother 
does not care for the baby due to substance misuse during her pregnancy, it can become a 
hasty generalization leading to the assumption that women who misuse during pregnancy 
are morally repugnant and not worthy of their baby.  False generalizations and 
assumptions occur when one relies on anecdotal stories alone (Church, n.d.).  Butler et al. 
(200l) administered a survey to 115 different educational institutions regarding curricula 
for providers who work with prenatal substance misuse.  The study revealed that while all 
educational systems expressed the need for continuing education, only 33% of physician 
programs, 29% of nursing programs, and 14% of social work programs offered any form 
of continuing education within the area of prenatal substance misuse (Butler et al., 2001).  
Provider training and education can potentially help providers both cope and offer best 
practices for a vulnerable population.  Women are not only hosts for a baby.  This type of 
thinking leads providers to only consider the needs of the baby and potentially vilify and 
lose prime access to assisting the mother (Stein, 2002). 
Legal Precedents 
During the 1980s, the medical community witnessed a stark increase in crack 
cocaine use among pregnant women.  Consequently, many states enacted laws requiring 
women to be referred to child service departments as perpetrators of child abuse (Benke 
& Smith, 2013).  Substance misuse during pregnancy was then categorized as criminal 
(Crawford et al., 2015).  Public Law 108-36, Keeping Children and Families Safe Act, 
was enacted in 2003, requiring hospital officials to contact their local child welfare 
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agency should intrauterine drug exposure be detected (Benke, & Smith, 2013).  However, 
such measures did little to curb addiction and the number of drug-exposed babies.  By 
default, it likely helped ignite the thought process towards criminalization versus disease, 
as evidence by the “War on Drugs” propaganda.  However, by late 2000, changes in 
societal perceptions of addiction began to take hold.  Changing the jargon from “War” to 
“public health issue” is an attempt to decriminalize addiction (Lemaitre, 2011) and focus 
more on the disease of addiction.  A blow to the public health issue belief occurred when 
Tennessee enacted SB2532.  This controversial bill allows for legal prosecution of 
women who use illicit substances during pregnancy, if linked to harm to the baby (Lollar, 
2017).  However, research has shown that such a law is detrimental to both mother and 
baby as seeking prenatal care is greatly diminished with an increase of home-births as a 
result of fear of prosecution (Burke, 2016; Church, n.d.; Lollar, 2017).  The medical 
community has staunchly opposed the bill, which was passed into law in 2014 (Burke, 
2016).  The law required individuals to secure treatment when there was no treatment 
available.  In short, the women were penalized for matters beyond the initial use.  
However, due to the negative ramifications of the bill, it was suspended in 2016 (Burke, 
2016; Lollar, 2017). 
By 2015, a bipartisan Congress approved the “Protecting Our Infants Act of 
2015.”  The Act aims to increase evidence-based practices for the care of mothers and 
their babies exposed to opioids (Botticelli, 2015).  The Department of Health and Human 
Services is championed with the role to study and recommend both treatment and 
prevention programs for opioid dependence (Botticelli, 2015).  With the relatively new 
act and President Trump’s acknowledgement of the opioid crisis, it is likely that new 
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models for treatment may soon be available.  It is promising that the focus on prenatal 
substance misuse is gaining greater attention with a potential narrative of a health crisis 
over criminality.  Additionally, with recent state legalization of marijuana and noting 
marijuana is the leading substance used in pregnancy, the manifestation of the addiction 
and provider reaction is yet to be understood. For example, prenatal use of marijuana may 
be seen as less egregious given the recent push for legalization, with eight states and the 
District of Columbia decriminalizing recreational marijuana use by 2018 (Robinson, 
2017).   
Currently, prenatal substance misuse triggers a referral to Child Protective 
Services (CPS) (Chasnoff, Landress, & Barrett, 1990).  Within the United States, each 
state has discretion on mandates for testing for prenatal drug use though federal laws 
require states to have an established reporting protocol (Benke & Smith, 2013).  In 
Indiana, hospital staff report prenatal substance misuse to CPS.  However, the extent of 
involvement is dependent upon the type of drug, history of use, home environment, and 
compliance with CPS.  In Indiana, CPS determines the level of involvement necessary, 
ranging from unsubstantiated (closing the referral), informal adjustment (IA), to a 
designation of Child in Need of Services (CHINS) (Indiana Department of Child 
Services, 2017).  A CHINS classification can lead to the baby being placed in foster care, 
with relative placement, or in-home placement while still a ward of the state.  There are 
also variations by county and state (Stone, 2015).   
Providers may still struggle with addiction as a health crisis as they must witness 
the devastating effects on babies.  It can be difficult for healthcare providers to recognize 
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the services in place for child protection due to confidentiality and due to the inability of 
NICU staff to witness the follow-up actions of child services.   
Theoretical Underpinnings for Addiction and Causes of Structural Stigma 
The first thoughts of illicit drug use may stir images of needles in alleyways or 
haphazard living conditions with pill bottles scattered about.  However, 70% of women 
with a drug-exposed baby received their first opioid from a medical provider 
(Winchester, 2012).  Often the drug use then spiraled into addiction.  There is not a 
shortage of theories surrounding the causes of addiction.  However, three positions that 
starkly contrast with each other are the Moral Model of Addiction, the Disease Model, 
and the Learning Model of Addiction.  These three models will be explored as the 
underpinnings of each model funnel into the concepts of stigma and more specifically, 
structural stigma.  
Moral model.  The Moral Model of Addiction focuses on the individual’s 
weakness and subsequent character flaws (Lawrence, Rasinski, Yoon, & Curlin, 2013; 
Ngo, n.d.; NIDA, 2014a; Schaler, 1991).  Drug addiction is viewed as caused by the 
person’s own poor choices and lack of willpower (NIDA, 2014b; Schaler, 1991).  
Religious entities were viewed as the expert in addictions; thus, religion became the 
driving force of the evolution of the Moral Model of Addiction (Ngo, n.d.).  Individuals 
who became addicts were seen as vile people with no moral compass (Ngo, n.d.; Schaler, 
1991).  Such thinking led to a punishment focus as the individual made bad decisions 
(Ngo, n.d).  The War on Drugs, which criminalized drug use over rehabilitation and 
promoted long prison sentences, is a prime example of our society’s global views of 
addiction (Lemaitre, 2011; Ngo, n.d.).  The moral model has been able to be sustained 
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because of its appeal to our common sense (Ngo, n.d).  Such statements as “we have free 
will, anyone could ‘just say no’…they are making a poor choice” led to the belief that 
drug use is born out of bad decision-making and inept moral positioning.  However, this 
simplistic view of drug use fails to explain the sociological and physiological effects of 
drug use (Lawrence, et al., 2013; Ngo, n.d).   
Over time, the Moral Model theory lost support (Lawrence, et al., 2013; Ngo, 
n.d.) as medical clinicians began to examine addiction and the community shifted to 
viewing medical professionals as the expert (Ngo, n.d).  Although the Moral Model of 
Addiction may have lost general support, one could argue that it is still alive and well in 
the day-to-day thinking of the community.  For example, in the NICU setting, it is not 
uncommon to hear such statements as:  “Why wouldn’t she just stop using when she is 
pregnant?” or “So now she cares about her baby? Why didn’t she care when she was 
pregnant and stop using drugs?”  Additionally, in Lawrence et al.’s (2013) quantitative 
study of physician beliefs regarding addiction, 14% reported the cause of addiction 
stemmed from a moral failing.  The Moral Model may not be openly promoted today, but 
it still appeals to the common core of many individuals, including healthcare workers.  
With healthcare workers and the community operating under the belief that drug use is 
pleasure-seeking, a punitive and criminal approach takes effect (Stein, 2002).  However, 
punitive approaches lead women to avoid prenatal care, withhold medical information, 
and isolate themselves out of fear (Lollar, 2017; Stone, 2015), often putting babies at 
further risk.   
Disease model.  The Moral Model of Addiction examines the moral compass of 
the individual; conversely, the Disease Model of addiction views addiction as a medical 
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condition, a defect of the brain (Horvath, Mizrah, & Epner, n.d.; Ngo, n.d; Schaler, 
1991).  Drug use alters the brain, thus, causing the individual to crave the drug and 
continue the destructive cycle.  The disease model argues that there are no cures for 
substance addiction, only recovery (Horvath, et al., n.d.; Ngo, n.d.).  Recovery occurs 
when the individual is able to abstain from use and actions leading to the use (Horvath et 
al., n.d.; Schaler, 1991).  This causes the disease or addiction to become dormant thus 
hindering the progression of the disease (Horvath, et al, n.d.).  Support groups and peer 
support are viewed as the leading resources for continued healing and sobriety (Horvath 
et al., n.d.; Ngo, n.d).  However, critics of the Disease Model protest that such thinking 
leads to a lack of ownership and personal responsibility (Lawrence et al., 2013; Ngo, n.d.; 
Schaler, 1991).  Additionally, beliefs that there is no cure and that drug addiction is not 
their fault may lead the individual to not seek treatment or believe that the behavior 
cannot be changed (Ngo, n.d.).  Like the Moral Model, the Disease Model is also present 
in the NICU.  When babies are drug-exposed, it is treated as a disease and has been 
labeled Neonatal Abstinence Syndrome.  The babies are treated with medication, feeding 
assistance, as well as neurological and developmental follow-up.  The babies are not 
considered to have a morally lost compass because they are withdrawing from opioids, 
cocaine, methamphetamine, etc.  
Learning model.  Like the Moral Model, the Disease Model lacks insight into the 
key factors leading to addiction.  The Learning Model of Addiction, however, takes into 
account the environmental factors leading to addiction (Ngo, n.d.; Schaler, 1991).  Such 
factors include self-medication due to mental health needs, family addiction, poor social 
and psychological influences, and poor coping mechanisms (Ngo, n.d.).  An individual 
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may turn to drug use to help escape a negative situation like domestic/physical/sexual 
abuse but then the drug use spirals into additional social stressors (poor housing, lack of 
employment).  Poor mental health can be a precursor to drug and alcohol misuse as 
individuals use substances for self-medication (NIDA, 2014a; Stein, 2002).  Parents may 
explain their drug use to NICU staff as being due to a lack of access to anti-anxiety 
medication and so they self-medicate using marijuana.  Or, they may take Adderall (an 
amphetamine) to help them focus and remain in control.  Additionally, women who use 
illicit substances have higher incidence of childhood sexual abuse and family history of 
substance misuse (Stein, 2002).  Although intellectually appealing, this model does not 
account for the role drugs play in altering the brain.  The initial cause for use can morph 
into a physical addiction (Stein, 2002; Winchester, 2012).  The individual continues to 
use to offset withdrawal and escape painful feelings (Ngo, n.d.; Stein, 2002).  In short, 
the drug becomes less pleasurable and more necessary to cope with daily life (Stein, 
2002).  Although such history does not excuse the behavior, it can explain the behavior 
and help to explain why substances were used during pregnancy despite the individual 
being aware of the negative ramifications for the baby.  One’s identity becomes that of 
drugs.  Consider that in rehabilitation programs, often the first words when addressing the 
group are:  “I am ____and I am a/an drug addict/alcoholic.”  The lifestyle can become 
ingrained and an individual may not be able to envision an alternative.  
Understanding Stigma 
These three models, while broad and varying in their context, individually offer 
an incomplete explanation of drug use and may inadvertently lead to health disparities.  
This research proposes that structural stigma may occur in the healthcare setting, 
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specifically in the pre and perinatal environment.  Such attitudes of healthcare providers 
may be affected by the above models, of which they may not be cognizant.  Thus, 
provider beliefs regarding drug use may lead to stigma.  Stigma can affect all areas of an 
individual’s life, including housing, employment, and relationships (Livingston et al., 
2012).   
Health disparities are largely exacerbated by stigma which leads to a lack of 
resources, poor social relationships, negative psychological and behavioral responses, and 
increased stress (Hatzenbuehler, Phelan, & Link, 2013).  Stigma encompasses a broad 
range of factors including, but not limited to, race, ethnicity, disabilities, HIV status, 
sexual orientation, mental health, obesity, and drug use (Hatzenbuehler, et al., 2013).  
Leading stigmatized health conditions include substance use disorders (Livingston et al., 
2012).  However, when substance use disorder co-occurs with pregnancy, the potential 
for stigmatization increases (Sun, 2004).  Studies have shown that women self-report 
lower levels of drug and alcohol use during pregnancy (Jacobson et al., 1991).  This may 
largely be in part due to stigma associated with use during pregnancy and fear of 
healthcare worker’s judgment (Jacobson et al., 1991).  The healthcare needs of the 
individuals may be negatively affected if they believe they cannot be honest with their 
healthcare provider.  Research has shown that the stigma of prenatal drug use acts as a 
deterrent for prenatal healthcare (Crawford et al., 2015; Stone, 2015).  Stigma also 
includes all labeling and stereotyping (Hatzenbuehler et al., 2013).  Stigma leads to 
isolation due to fear of provider reaction and rejection (Hatzenbuehler et al., 2013; 
Marangoni & Felix de Oliveria, 2015), which may lead to poor maternal and fetal care, 
poor hospital visitation, or lack of attentiveness in the NICU.   
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Stigma occurs for varying reasons.  Link and Hatzenbuehler (2016) identified 
three contributory factors leading to stigma, namely:  “keeping people down,” “keeping 
people in,” and “keeping people away” (pp. 656-657).  “Keeping people down” is 
attributed to the mindset that one group must be superior.  If one group is able to be 
oppressed then that ensures the power/status of the remaining group (Link & 
Hatzenbuehler, 2016).  Conversely, “keeping people in” helps to enforce social norms 
thus keeping social order (Link & Hatzenbuehler, 2016).  Lastly, “keeping people away” 
is not allowing the affected individual near.  This is not only the physical disease 
(coughing, sneezing, etc.) but the internal disease of addiction (Link & Hatzenbuehler, 
2016).  The three factors are not mutually exclusive (Link & Hatzenbuehler, 2016).  All 
three or any combination likely plays a role in the manifestation of stigma within a 
healthcare setting.   
Within the healthcare field, structural stigma is well-documented in the 
HIV/AIDS population (Pescocolido & Martin, 2015).  According to Stringer et al.’s 
(2016) quantitative study on stigma towards the HIV/AIDS population among health 
professionals, increased structural stigma occurs when employees do not feel that policies 
are enforced to ensure safety, education is not provided, and healthcare worker’s access 
to safety supplies is limited.  The “keeping people away” factor may then arise as 
healthcare workers do not feel safe and thus react negatively.  Additionally, such 
examples in a healthcare setting may include the drug misusing mother not being 
encouraged to visit or participate in the care of her baby because of fear from healthcare 
providers that she may be under the influence, despite a lack of evidence of current drug 
misuse.  This may contribute to “keeping people away” as she is considered an unfit 
30 
caregiver.  In an effort to maintain social order, the staff may continue to place blame on 
the parent and become highly critical of her.  Because the mother is viewed as the abuser, 
the staff may see themselves as the baby’s protector and the best one to care for the baby.  
Varying types of stigma.  There are varying types of stigma:  self, social, and 
structural (Livingston et al., 2012).  Self-stigma can be conceptualized as negative 
thoughts and feelings regarding one’s self, acceptance of one’s stereotypes due to past 
experience, and the expectation of negative attitude/reactions of others due to status or 
health condition (Livingston & Boyd, 2010).  Self-stigma can lead to self-destructive 
behaviors and may contribute to poor health outcomes (Hatzenbuehler et al., 2013).  A 
vicious cycle ensues; individuals believe the negative attributes that are assigned which 
causes continued maladaptive emotional coping strategies (Hatzenbuehler et al., 2013), 
leading to a self-fulfilling prophecy thereby giving credence to the stigmatizer’s beliefs.  
Social stigma occurs when a large group engages in stereotyping and negative actions 
against an already stigmatized group (Corrigan, Kerr, & Knudsen, 2005).  The 
individuals do not fit the social norm of society and are thus excluded (Overton & 
Medina, 2008).  For individuals with drug misuse, their actions toward sobriety may not 
be seen as genuine as they have been rendered a “drug abuser” and morally flawed.  
Lastly, structural stigma includes public institutions with agents that promote negative 
actions and attitudes towards a group (Corrigan et. al, 2005; Corrigan, Watson, Heyman 
et al., 2005; Link & Hatzenbuehler, 2016).  This type of stigma suppresses opportunities 
for the stigmatized group, promotes a loss of status, labeling, discrimination, and 
stereotyping (Corrigan et al., 2005; Corrigan et al., 2005; Link & Hatzenbuehler, 2016).  
Structural stigma largely follows an “us versus them” narrative.   
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Structural stigma.  Structural stigma broadly encompasses the policies and the 
culture within an institution.  Structural stigma may occur both directly and indirectly 
causing the stigmatized group to not be able to fully experience all resources (Corrigan, 
Markowitz, & Watson, 2004; Corrigan et al., 2005).  An example of indirect occurrence 
includes staff reluctance to include the post-partum mother in the day-to-day care of her 
newborn experiencing NAS.  Additionally, substances that are viewed as more egregious, 
like heroin or cocaine, lead to policy (both formal and informal) implications that 
criminalize the behavior, which thus perpetuate the stigmas (Ahern, Stuber, & Galea, 
2007).  Substance use disorders are also linked to structural stigma as, overwhelmingly, 
people with such disorders are viewed as having the ability to stop the drug use and such 
actions to not do so are thought to demonstrate their negative moral compass (Corrigan, 
Kuwabara, & O’Shaughnessy, 2009), circling back to the Moral Model of Addiction.  
Ahern et al.’s (2007) quantitative study, which included more than 1,000 individuals 
currently misusing substances, reports that nearly 77% of respondents feel that people 
believe they are a bad person because of their drug use.  Additionally, 24% of 
respondents felt that they were unable to receive needed medical care due to their drug 
addiction (Ahern et al., 2007).  
Fundamental Cause Theory.  Within the stigma field, several additional theories 
surface.  Fundamental Cause Theory examines not only the socio-economic factors but 
also the access to knowledge, money, power, prestige, beneficial social connections, 
health inequalities, and outcomes for addiction (Hatzenbuehler et al., 2013).  The general 
context is that individuals with more money, power, prestige, and social connections have 
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greater advantages and health services/outcomes (Hatzenbuehler et al., 2013).  Such 
ramifications can be observed within the NICU setting.   
Relationships play a major role within a NICU, and if the individual is perceived 
as “bad,” the individual’s power to be a part of the medical team can be affected.  The 
prestige of being the baby’s mother diminishes and staff usurps the parental role.  The 
parent thereby may have limited social connection to staff or baby.  This can cause the 
parents to develop negative feelings towards the NICU staff and thus limit their desire to 
remain connected.   
Hospitals around the country are beginning to reassess the treatment of NAS and 
have found promising results by humanizing the individual.  In a Tennessee hospital, the 
program functions under the paradigm of addiction as a disease over a moral flaw 
(Busenbark, 2016).  By decreasing providers’ disapproval and subsequent anger toward 
the mother’s drug use, providers are able to better support the baby and parent 
(Busenbark, 2016).  Such changes in the treatment of NAS lowered the length of stay 
(LOS) from 34 days to 23 days in a Tennessee area NICU (Busenbark, 2016).  The 
decrease in LOS is attributed to staff and community education and a shift in the beliefs 
about addiction (Busenbark, 2016).  Similarly, the Yale-New Haven Children’s hospital 
changed the underlining belief system of drug-exposed babies and placed the parents in 
the center of the treatment/care process (Busenbark, 2016).  The parents are included in 
the treatment plan to help administer the non-pharmacological support.  The hospital 
team is empowering women to become the healing component which helps to increase 
the trust and relationship between staff and caregiver (Busenbark, 2016).  After two years 
of implementing this approach, Yale-New Haven Children’s Hospital experienced a $4 
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million reduction in costs due to a decrease in length of stay from 27.5 days to 7.5 days 
(Busenbark, 2016). 
Status Characteristics Theory.  Status Characteristics Theory posits that the 
stigma of the individual must be proven untrue before the group will accept an alternative 
belief (Hatzenbuehler et al., 2013).  For example, the medical team deems a parent unable 
to care for the drug-exposed baby; collectively, the group believes this as truth.  The 
burden lies on the parent to disprove the belief and regain the power to care for the baby.  
For this to occur, the individual must be able to overcome self-stigma and not fall into the 
perpetual cycle.  
Continued research on structural stigma is necessary to better understand the 
consequences of structural stigma and potential interventions (Hatzenbuehler, 2016; Link 
& Hatzenbuehler, 2016).  Stigma, structural or otherwise, does not solely affect one 
domain of a person’s life (Link & Hatzenbuehler, 2016).  There is limited research 
available on structural stigma and healthcare facilities for women pre/perinatally.  
However, research in other areas of healthcare, like HIV, showed a higher link to 
favorable treatment when the individual experienced limited structural stigma 
(Hatzenbuehler, 2016).  Although emerging research is available on structural stigma, it 
remains in the early stages of understanding and development (Hatzenbuehler, 2016).  
Further study of structural stigma, particularly in the maternal/fetal domain, will enhance 
the understanding of health inequalities and increased success of interventions 
(Hatzenbuehler, 2016). 
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Study Rationale 
 Although the field of research surrounding general NAS and addiction is robust, 
there is a dearth of research regarding healthcare provider attitudes across disciplines and 
potential structural stigma regarding prenatal substance misuse (Fonti, Davis, & 
Ferguson, 2016).  Beyond the traditional healthcare providers of medical doctors and 
nurses, there is a host of ancillary staff such as social workers, chaplains, supportive care 
workers, case managers, ultrasound technicians, dietary services, physical therapists, 
speech therapists, occupational therapists, managerial nurses, lactation consultants, and 
volunteers.  All of these providers play a role in the hospital experience of pregnant 
women.  Each group may have a different understanding or belief and can negatively or 
positively affect the outcome.  The case manager’s role is often to gain insurance 
approvals for hospital stays and procedures while the physical/speech/occupational 
therapy roles assist with education around current and ongoing physical needs.  Social 
workers are the gatekeepers to notify Child Protective Services, provide referrals to 
addiction and community resources, as well as support.  Chaplains offer emotional and 
spiritual support while dietary helps to improve nutrition for the mother while also 
serving to ensure maximum growth for the baby.  Directors assist with policy and 
procedures, and managers often provide supervision.  All of these different disciplines, 
whether directly or indirectly, play a vital role in the mother and baby’s life.  Yet, there 
stands a major gap in the literature as to the effects, beliefs, and attitudes of the healthcare 
team when working with substance-exposed babies and their families.  
No studies were found that assessed the attitudes of the multi-disciplinary team of 
healthcare workers who are involved in the care of women suffering with substance 
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misuse and their babies.  A few studies like Selleck and Redding’s study from the mid-
1990s examined the attitudes towards prenatal substance misuse of 392 nurses.  The 
results indicated that more than half of nursing staff reported negative or punitive 
attitudes towards the women.  However, staff with greater education on addiction had 
more positive attitudes (Selleck & Redding, 1998).  The study included only nursing 
staff, which reflects a limitation as many different disciplines are involved in the care of 
both mother and baby.  Similarly, Fonti et al.’s (2016) survey of nurses indicated neutral 
to slightly positive overall attitudes towards prenatal substance misuse (Fonti et al., 
2016).  Additionally, the majority of healthcare providers indicated that they believe they 
have the power, professionally, to make a positive difference for the mother (Fonti et al., 
2016).  Raeside’s (2003) quantitative study also examined attitudes of midwives and 
nursing staff (n=50) relating to prenatal substance misuse and found negative staff 
attitudes.  The self-report results indicated that 98% believe it is important to encourage 
the maternal/baby bond though 76% report anger towards the mother (Raeside, 2003).  
Additionally, 76% of participants reported feeling that they were unable to effectively 
meet the psychological needs of the new mothers.  Howell and Chasnoff (1999) 
conducted 33 focus groups of hospital and community workers and women with prenatal 
substance misuse.  The focus of the study was to better understand the needs of women 
with prenatal substance misuse rather than staff attitudes and structural stigma.   
 Other such research examines attitudes on substance use disorders in pregnancy.  
Bland, Oppenheimer, Brisson-Carroll, Morel, and Holmes (2001) reviewed attitudes of 
medical students (n=84) towards substance misusing pregnant women.  The results 
indicated a positive change in medical student attitudes after education regarding 
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addiction was presented (Bland, et al.., 2001).  Silins et al. (2007) surveyed more than 
400 medical students about their attitudes towards drug misuse.  The survey was 
administered prior to an intensive educational intervention regarding substance misuse 
(Silins et al., 2007).  The education included not only classroom work but also focus 
groups with individuals experiencing substance misuse (Silins et al., 2007).  The survey 
was administered again at the end of the educational series (Silins et al., 2007).  Silins et 
al. (2007) used an adapted Alcohol and Alcohol Problems Perception Questionnaire 
(AAPPQ) to assess student attitudes.  The medical students’ overall attitudes toward 
substance misuse improved with increased education (Silins, et al., 2007).  However, 
Ford, Brammer, and Becker’s (2003) cross-sectional survey of nursing attitudes indicated 
that education alone is not sufficient to improve the attitudes of staff when working with 
maternal substance misuse. It is likely that additional emotional and social supports are 
necessary. 
Social workers have a unique ability to be leading researchers and practitioners by 
developing and implementing programs, changing policy, and guiding development 
practices.  The goal of this study was to assess the attitudes and structural stigma across 
multiple disciplines within a healthcare system towards women who use illicit substances 
pre/perinatally.  Such research may lead to a greater understanding as to proactive 
measures to decrease the structural stigma of prenatal substance misuse and increase 
support for healthcare providers.  Research is necessary to assist in identifying support 
and education gaps for providers and to recognize the unique challenges facing healthcare 
providers across disciplines who work with drug-exposed babies.  Overall, families and 
healthcare providers may not be receiving the needed support which can then impact 
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care, performance, and safety.  Prenatal substance misuse is a public health concern and it 
is necessary to continue the research to ensure best practices and supports, both for the 
mother/baby and the healthcare providers. 
Research Question and Hypotheses 
 This project examined several variables to explore structural stigma towards 
women with prenatal substance misuse within a healthcare unit.  The research question is 
a broad inquiry about the relationship among the study variables (Creswell, 2008). What 
are the healthcare practitioners’ perceptions, attitudes, and level of structural stigma 
towards prenatal substance misuse? 
The following hypotheses build on the research question and test some of the 
conceptual framework of the body of knowledge (Creswell, 2008) about the effects of 
working with babies suffering with NAS and attitudes of prenatal substance use.  See 
Table 1 for a complete list of hypotheses, variables, and analysis methods. 
H1: The area of employment practice and level of supervision will be predictive 
of healthcare providers’ attitudes and level of structural stigma towards women with 
prenatal substance misuse. 
H2:  Healthcare providers’ expressed statement of their belief of causation of 
substance misuse will be predictive of their attitudes towards women with prenatal 
substance misuse.  
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Chapter Three:  Research Methods 
Research Design 
 The design of the study was a cross-sectional, exploratory survey.  The survey 
design allowed for a greater ability to estimate from the sample to the population 
(Dillman, 2007).  Other design modes like focus groups, small group experiments, 
content analysis, and historical analysis do not allow for such estimation (Dillman, 2007).  
The study was exploratory in nature because it sought to shed light on the emerging 
connection between attitudes towards drug-exposed babies and their families and 
structural stigma (Rubin & Babbie, 2011).  Although a cross-sectional design with a one-
time sample of participants allowed for insights into association within the study 
(Hatzenbuehler, 2016), this type of design was not able to capture changes over time 
(Rubin & Babbie, 2011).   
Study Participants 
 The group under investigation were healthcare practitioners within a 
maternal/fetal and prenatal healthcare setting.  There are several reasons for focusing on 
this group of practitioners.  The care provided for babies experiencing NAS and their 
mothers requires a team approach (Busenbark, 2016).  As such, the hospital staff that 
provides care includes nursing, neonatology, dietary, social work, chaplaincy, high risk 
obstetric care, speech/physical/occupational services, case management, ultrasound, 
lactation specialty, language services, and NICU general staff.  Thus, multiple disciplines 
are involved in the care of mother and baby.  All medical practitioners, regardless of 
discipline within the maternal fetal setting, are ideal for the study because these 
practitioners are most likely to be delivering clinical intervention, are at risk of 
perpetuating structural stigma, and may experience burnout associated with the highly 
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stressful environment.  The main inclusion criteria for this sample was actively practicing 
in the healthcare field (employed either part-time or full-time) at the time of data 
collection.  Participants who are not currently practicing in the healthcare field were 
excluded from the study. Additionally, they were required to practice within the maternal, 
neonatal, or pediatric areas. Due to the format of the survey participants also were 
required to be able to read English.   
 The sample was a non-representative, convenience sample of healthcare 
professionals in Indiana.  Although probability sampling increases the potential for non-
biased sampling due to the nature of the study, due to financial and resource constraints, 
it was not feasible (Henry, 1998).   
To recruit healthcare providers willing to complete the survey, the researcher 
sought contact with the largest pediatric hospital in the state of Indiana.  The Indiana 
University Hospital System including Riley Children’s Hospital, Eskenazi Health, 
Methodist at Indiana University, and University Hospital at Indiana University, is the 
largest pediatric hospital and offers the highest level of care (level IV) in the state.  The 
researcher contacted the individual medical directors and department managers directly 
and offered an opportunity to participate in the study. A personalized invitation e-mail 
was sent (see Appendix A).  The medical directors and managers were asked to send the 
survey to their staff via the Internet through a participant recruitment e-mail written by 
the researcher (see Appendix B).  By asking the medical directors and managers to send 
out the recruitment e-mail and survey link, the protection of staff information was better 
ensured.  A follow-up e-mail with a study time frame and a message of appreciation was 
sent to all agreeing medical directors and managers (see Appendix C).   
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Sample Size 
To determine an appropriate sample size, multiple factors including type of 
statistical test, the significance level, the expected effect size, the targeted value of power, 
and the estimated response rate for the survey was assessed (Olejnik, 1984).  The 
conventional social science alpha level of .05 was used; thus, there is a 5% chance that 
false significance, or type 1 error, will occur (Olejnik, 1984).  A medium effect size, the 
strength of difference between two or more variables, was used as this is conventional in 
social science research (Olejnik, 1984).  A factorial Multivariate Analysis of Variance 
(MANOVA) was used to analyze the data to test the first hypothesis.  Based on the use of 
the MANOVA, a medium effect size of .15 was used in this study (Newton & Rudestam, 
1999).  The generally accepted minimum for power is .80, to decrease the possibility of 
Type II error, thus, an 80% chance of finding statistical significance when there is 
significance.  The Daniel Soper Statistical Calculator (2011) was used to calculate the 
sample size with the above criteria and the five predictor variables.  The survey required 
a target sample of 91 participants. Since response rates for Internet surveys can be as low 
as 25% (Munoz-Leiva, Sanchez-Fernandez, Montoro-Rios & Ibanez-Zapata, 2010), the 
goal was to reach 364 potential participants to get a sample size of 91.  Initially 135 
individuals opened the survey link, 127 individuals started the survey, and 117 completed 
the survey.  The participants came from pediatric and maternal medicine units of Indiana 
University Health.  The researcher was unable to report the number of employees who 
may have received the survey as the number of employees in each department was not 
known.   
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IRB approval was granted from Indiana University.  Additionally, the Riley 
Hospital for Children medical director reviewed the survey and IRB approval prior to 
allowing data collection. 
The survey was disseminated to healthcare providers, via their manager or 
medical director, by an e-mail with a web link to the survey software tool.  Staff were 
invited to participate in all departments that may have interactions with women with 
prenatal substance misuse and children affected by prenatal substance misuse.  For 
example, a woman with substance misuse may be staying on a cardiac unit rather than 
obstetrics to ensure proper medical safety if she has additional needs.  It was important to 
capture all staff that may interact with the mother and baby, even if the instances were 
minimal.  A reminder e-mail about the survey with the link was sent 10 days after it was 
initially sent (see Appendix D).  One medical director reported after she received the 
reminder e-mail she realized she had failed to send out the original survey.  She then sent 
out the original survey and contacted the researcher after she sent the reminder email, 10 
days later.  The directors/managers were not contacted with a second reminder as the 
desired sample size was reached.  In addition, more than one reminder may have been 
difficult for the director to send out on behalf of the researcher.  Individual contact 
information was not available thus sending the reminder e-mails relied on the 
directors/managers.  The researcher was available if directors/managers had questions or 
concerns.  Respondents had the opportunity to enter a drawing to win a $10 Amazon gift 
card.  One participant per every 250 respondents in the drawing was randomly selected 
for the gift card.  In this case, one respondent was chosen as there were 117 participants.  
After completing the survey, respondents had the opportunity to choose to enter the 
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drawing.  Respondents were taken to a new survey to enter only the contact information 
of name and email address.  The respondents name was not linked to the initial survey.  
The winner was selected using the “sweepstakes generate winner” function through 
Qualtrics.  Individuals were also encouraged to participate to help increase the body of 
literature surrounding healthcare providers’ attitudes and perceptions of prenatal 
substance misuse.  
Measures 
The key variables in this study included healthcare provider attitudes and 
perceptions of prenatal substance misuse, structural stigma, and beliefs about causation of 
substance misuse.  A practitioner’s employment discipline and level of supervision were 
used as predictor variables.  Of particular interest was the variable of employment 
discipline, as little to no research is available on this factor.  Demographics served as 
additional control variables.  
 Healthcare provider attitude and stigma.  To assess healthcare provider 
attitudes, a request was sent to Ms. Lavinia Raeside for access to her questionnaire from 
2003.  However, after reaching out by e-mail and through ResearchGate message board, 
there was no return contact from Ms. Raeside.  No new contact information for Ms. 
Raeside was available.  The full survey was not found in the public domain.  However, a 
request to Mr. Edmund Silins for the use and modification of the questionnaire from 
Alcohol and Alcohol Problems Perception Questionnaire (AAPQ) was made and granted 
(Silins, Conigrave, Ravkin, Dobbins, & Curry, 2007).  Mr. Silins provided written 
documentation allowing for the use and modification of the survey (see Appendix E).   
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The researcher developed a new measure to assess belief of causation of 
substance misuse, stigma, and attitudes toward prenatal substance misuse based upon the 
work of multiple contributors (see Appendix F) (Raeside, 2003; Silins et al., 2007; 
Stringer, 2016).  The measure is a 35-item scale broken into 3 groups, attitudes scale, 
structural stigma scale, and causation of substance misuse scale. Each of the items, which 
included statements such as “I am uncomfortable working with pregnant cocaine users” 
and “I believe more punitive measures should be taken against a mother with pregnancy 
drug misuse,” are rated on a 5-point Likert scale (1 = strongly agree to 5 = strongly 
disagree).  Six items were reverse-coded.  Lower scores indicate more negative attitudes 
and stigma related to prenatal substance misuse.  The items used to assess provider 
attitudes were modified from Silins (2007) (Q13-Q28). Questions 40 and 47 were added 
to the attitudes scale as they were specific to this study.  Eleven items were developed to 
assess structural stigma (Q32, Q35, Q36, Q47, Q48, Q49, Q50, Q51, Q53, Q54, Q55).  
The items were based upon previous available research (Raeside, 2003; Stringer, 2016).  
For full reference of the survey items used for each scale, please see Table 2. 
Control variables.  Twenty-two (22) additional questions were added for 
demographics and greater understanding of respondents’ views.  Demographic items 
inquired about respondents’ education level, position status (full or part-time), 
professional licensure status, race, ethnicity, age, practice location, length of time in 
practice, and gender.   
Pretesting.  To best assess if the questions were relevant, easy to understand, and 
applicable to the target sample, pre-testing of the survey was completed (Czaja & Blair, 
2006).  This study had multiple levels of pre-testing.  The first was a review from the 
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dissertation committee who provided essential feedback on the instrument.  Additionally, 
Dr. Glassburn reviewed the survey and offered vital feedback.  In addition to committee 
review, the researcher asked eight professionals in the healthcare field, including social 
work, nursing, dietary, and speech therapy to fill out the survey.  An e-mail was sent with 
a Qualtrics link to the survey.  Respondents reported survey completion was around 10 
minutes and no concerns were noted. The pilot-test process allowed for additional 
feedback and to assess the initial face validity and reliability of the tool (Czaja & Blair, 
2006).  The scales for Attitudes, Structural Stigma, and Causation of Substance Misuse 
were tested for internal consistency using Cronbach’s Alpha coefficient.  The Attitudes 
Scale (a=.89), Stigma Scale (a=.785), and Causation of Substance Misuse Scale 
(a=.802), met the parameters for appropriate internal consistency at the acceptable to 
high range. 
Data Collection 
Data analysis was conducted using the SPSS software (IBM SPSS, 2011) as it is 
compatible with Qualtrics.  To reduce the potential error of entering data by hand, the 
information was uploaded directly from Qualtrics to SPSS.  Factorial MANOVA, 
correlations, and descriptive analyses were used to assess the data.  Factorial MANOVA 
was used as it allows for testing mean differences between levels of two independent 
variables with two dependent variables (French et al., n.d.) and reduces the Type 1 error 
rate (Daui Wei Ling, 2011). 
Independent variables.  The research study examined two independent variables:  
employment discipline and perceived level of supervision. Both were examined at the 
categorical level.  Specifically, employment discipline was nominal.  Employment 
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discipline consisted of 24 possible selection options, including an “other” category.  
Within the employment discipline question, 13 different positions were selected by 
participants. As some employment discipline groups contained as little as one member, 
the employment disciplines were consolidated to six fields. The consolidated categories 
included Medical Doctor, Nurse Practitioner/ Physician Assistant, Direct Care Nurse, 
Administration, Social Work, and Support Staff. Table 3 shows the complete 
representation of all employment disciplines and the consolidated groups.  To assess the 
perceived level of supervision, respondents were asked to choose from a 5-point Likert 
scale (1= strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree).  As a 
numerical difference could not be identified between the five groups, perceived 
supervision was used as an ordinal variable (Hinkle, Wiersma, & Jurs, 2003). 
Dependent variables.  The dependent variables, Structural Stigma and Attitudes, 
served as continuous variables. The Attitude Scale was created by using the sum score of 
questions Attitude 1-Attitude 18. Attitude 18 was reverse-coded.  Respondents chose 
from a 5-point Likert scale (1= extremely agree, 2=agree, 3=neutral, 4=disagree, and 
5=extremely disagree).  The sum score was then computed.  The sum numbers were 
divided into 5 groups:  Extremely Negative Attitudes (18-32), Negative Attitudes (33-
47), Neutral Attitudes (48-62), Positive Attitudes (63-77), and Extremely Positive 
Attitudes (78+).  The mean score (m=-60.19, SD=14.85) of all participants represents a 
generally neutral attitude toward prenatal substance misuse.  Reliability was tested with 
Cronbach Alpha of 0.959, which indicated excellent internal consistency (see Table 4 for 
inter-item correlation matrix).   
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The Structural Stigma Scale was created by using the sum score of Stigma items 
1-11.  Stigma 2, 3, and 9 were reverse-coded.  Respondents chose from a 5-point Likert 
scale (1=extremely agree, 2=agree, 3=neutral, 4=disagree, 5=extremely disagree).  The 
sum score was then computed.  The sum numbers were divided into 5 groups:  Extremely 
High Stigma (11-19), High Stigma (20-28), Neutral (29-37), Low Stigma (38-46), and 
Extremely Low Stigma (47-55).  The mean score (m=34.70, SD=5.07) of all respondents 
represented a generally neutral level of structural stigma toward prenatal substance 
misuse. Reliability was tested with Cronbach Alpha of 0.72, which indicated acceptable 
internal consistency (see Table 5 for the inter-item correlation matrix).    
Descriptive statistics were calculated to determine study participant characteristics 
and qualities.  These findings provided a contextual framework of the study sample and 
the relationship between participants and their beliefs and attitudes toward prenatal 
substance misuse (see Table 6). 
Assumption testing.  In preparation for the factorial MANOVA for research 
question 1, a series of tests were completed to ensure the assumptions for the MANOVA 
analysis were met. The Assumption of Multivariate was assessed as employee scores 
were independent of one another and all participants could only complete the survey one 
time.  The employee discipline affiliations were condensed to yield a higher sample size 
for each group.  The groups, as noted earlier, were reconfigured to include Medical 
Doctor, Nurse Practitioner/Physician Assistant, Direct Care Nurse, Social Work, 
Administration, and Support Staff.  
The dependent variables were continuous and measured at the interval level while 
the independent variables were categorical, each with five mutually exclusive and 
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exhaustive groups.  Across the dependent variables, the measure of skewness and 
kurtosis, histograms, and normal Q-Q plots were examined.  The results indicate a normal 
distribution and kurtosis is not significant (-0.66).  Additionally, Mahalanobis Distance 
(8.70) was used to test for multivariate outliers, which is within the critical value range 
(2(13.816)), p<.001 (Hinkle, Weirsma, & Jurs, 2003). 
The Pearson Correlation was used to test the assumptions that each dependent 
variable was moderately correlated.  Pearson Correlation was performed on the 
dependent variable scales:  Attitude Scale and Structural Stigma Scale. The results 
indicate the appropriate use of the MANOVA as the dependent variables -- attitude and 
structural stigma -- were significantly correlated (r=0.602, p<.01), indicating a strong 
correlation without multicollinearity (see Table 7). 
The assumption of homoscedasticity, i.e., that the covariances of all dependent 
variables across the levels of independent variables are equal, was measured using Box’s 
M test.  The Box’s M value of 44.67(p=.688) indicates the covariate matrices between the 
groups were assumed equal for the MANOVA (see Table 8).  
The homogeneity of variance assumption was tested for Attitude Scale and 
Structural Stigma Scale.  Using Levene’s F test, the assumption that all dependent 
variables has equal variance across all independent variable(s) groups, was satisfied as 
neither were statistically significant (Attitude Scale, p=.355 and Structural Stigma 
Scale=.514).  All assumptions were met thus rendering MANOVA an appropriate 
statistical analysis. 
   Additionally, correlations were calculated for the perceived causation of 
substance misuse scale and attitude scale of prenatal substance misuse. The causation 
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scale was created by using the sum score of C1-C5, with C1 reserve-coded.  The sum 
scores were calculated and then five groups were formed:  Highly Moral Flaw (5-8), 
Moral Flaw (9-12), Unsure (13-17), Disease (18-21), and Highly Disease (22+).  The 
mean score (m=13.38, SD=3.72) of all respondents represented a generally unsure belief 
of cause of substance misuse (disease vs moral).  For this study the Learning Model was 
not measured.  Reliability was tested with a Cronbach Alpha of 0.798, which indicated 
acceptable internal consistency. See Table 9 for the inter-item correlation matrix.  The 
variables for causation of substance misuse and attitudes -- were continuous. The 
attitudes scale was used as previously described.  The Q-Q plots for Attitudes Scale and 
Causation Scale were reviewed and revealed a linear pattern. 
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Chapter Four:  Results 
Study Participants 
 Demographics. The study sample (n=135) included respondents from a large 
hospital system in Central Indiana.  However, after data cleaning to remove incomplete 
surveys, the sample size was reduced (n=117).  The sample was overwhelmingly female 
(94%) and Caucasian (92%).  Participant ages ranged from 21 to 73 years.  See Table 10 
for a full review of demographic characteristics of respondents. 
Practice and employment. Of the 24 employment disciplines listed, the most 
common positions reported were Direct Care Nurse (41%), Medical Doctor (13%), Nurse 
Practitioner (14%), or Social Worker (13%).  In terms of employment status, more than 
94% of respondents were actively practicing in a maternal, fetal, or pediatric setting and 
86% were currently working with a mother or baby affected by NAS.  Most respondents 
reported they were full-time (73%) employees, and 20% reported spending more than 
51% of their work week in direct contact with substance misusing mothers.  Of the 
respondents, 55% reported they had been in their current position for more than 10 years. 
General attitudes and beliefs. Several survey questions were used to gain a 
better understanding of the medical system, as a unit, in terms of beliefs related to 
prenatal drug misuse.  More than 43% of respondents viewed their hospital system as 
providing a supportive environment, and more than 72% were satisfied with the level of 
communication between disciplines. Additionally, only 8% of respondents reported 
burnout from working with mothers who misuse substances, and more than 43% reported 
their schooling provided them with adequate education to discuss health risk behaviors.  
While 36% of respondents believed that the person could quit illicit substances if they 
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wanted to and 36% reported a person who misuses substances cares more about the drugs 
than the baby, roughly 9% of respondents reported no empathy towards women with 
substance misuse.  Interestingly though, 49% of respondents viewed substance misuse as 
a disease, and only 10% reported substance misuse as a moral flaw.  Forty percent of 
respondents believed the state should impose greater sanctions overall, with an additional 
35% requested more punitive consequences.  Additionally, 32% of respondents reported 
the hospital provides better non-medical care than mothers with substance misuse. Refer 
to Table 6. 
Hypotheses Findings 
Hypothesis 1.  For hypothesis 1, the area of employment practice and level of 
supervision will be predictive of healthcare providers’ attitudes and level of structural 
stigma towards women with prenatal substance misuse, the results of the factorial 
MANOVA showed an overall significant difference between an employee’s attitudes and 
stigma levels among different disciplines (Pillai’s Trace= 3.24, F(10, 198)=.28, p=.001) with 
a power of 0.987.  However, there was no significant difference between an employee’s 
attitudes and stigma levels among perceived levels of supervision (Pillai’s Trace= 2.04, 
F(6,198)=.116, p=.062).  Additionally, no significant differences were found between an 
employee’s attitudes and stigma levels among perceived level of supervision combined 
with discipline (Pillai’s Trace=1.3, F(18, 198)=.211, p=.194) (see Table 11). 
The results of the post hoc analyses between-subjects indicated attitudes 
(F(10,198)=4.63, p=.001, դ2=0.141) and stigma levels (F(6,198)=2.64, p < .05, դ2=0.118) 
differs significantly based on employment discipline.  The employee’s discipline 
accounted for 11.8% of the variance in attitudes (դ2=0.118).  While, employee’s 
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discipline accounted for 18.9% of the variance in structural stigma (դ2=0.189).  Medical 
Doctors indicated less negative attitudes (MD=9.80, p< 0.05), CI95= (1.71, 17.89) and 
decreased structural stigma (MD=3.73, p> 0.05), CI95= (-1.84, 8.78) compared to Direct 
Care Nurses.  Direct Care Nurses indicated more negative attitudes (MD=-14.37, p< 
0.001), CI95= (-22.27, -6.48) and more structural stigma (MD=-3.45, p< 0.05), CI95= (-
6.17, -0.74) over Social Workers.  Direct Care Nurses indicated more negative attitudes 
(MD=-9.94, p< 0.05), CI95= (-17.66, -2.22) and more structural stigma (MD=3.91, p< 
0.005), CI95= (-6.52, -.95) than Nurse Practitioners/Physician Assistants.  Social 
Workers indicated fewer negative attitudes (MD=13.19, p< 0.05), CI95= (3.49, 22.88) 
than Support Staff.  However, there was not a statistically significant difference among 
levels of structural stigma between Social Work and Support Staff (MD=.25, p=0.882), 
CI95= (-3.09, -3.59).  Direct Care Nurses indicated higher structural stigma (MD=-3.20, 
p< 0.05), CI95= (-5.92, -0.49) than Support Staff but there was no significant difference 
among attitudes (MD=-1.19, p=0.766), CI95= (-9.08, 6.71). There were no other 
significant findings between type of discipline and attitudes and structural stigma (see 
Table 12). 
The results of the factorial MANOVA showed there were no significant 
differences between attitudes (F (10,198) = 1.93, p > 0.05, դ2 = 0.055) and structural stigma 
(F (10,198) = 1.92, p >0.05, դ2 = 0.055) and the perceived level of workplace supervision, 
with a power of .732.  The level of perceived workplace supervision accounted for 5.5% 
of the variance in structural stigma (դ2 = 0.055). There was no significant finding 
between the perceived level of supervision and discipline among staff attitudes (F 
(18,198) = 1.25, p >0.05, դ2 = 0.102).  Additionally, there were no significant findings 
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between perceived level of supervision and discipline among structural stigma (Pillai’s 
Trace= 0.211, F (18,198) = 1.58, p > 0.05, դ2 = 0.126).  The employment discipline and 
level of supervision together did not influence the attitudes and level of structural stigma 
among employees.  Please refer to Table 13 for full multivariate means. 
Hypothesis 2.  For hypothesis 2, hyealthcare providers’ expressed statement of 
their belief of causation of substance misuse will be predictive of their attitudes towards 
women with prenatal substance misuse, a Pearson Correlation was conducted to 
determine a correlation between the perceived view of the cause of substance misuse and 
attitudes of practitioners.  Prior to completing the correlation analysis, the distribution 
and linear relationship was checked and passed the assumptions.  There was a high 
positive correlation (r=0.612, p< 0.01) between the belief in the causation of substance 
misuse and attitudes of practitioners.  As the causation of substance misuse increased 
towards a disease model, attitude scores increased.  Higher attitudinal scores indicated a 
more positive perception of women with prenatal substance misuse.  Higher scores on the 
causation scale indicated a belief that substance misuse is a disease versus a moral flaw. 
Thus, the null hypotheses, that no relationship between a person’s belief of the causation 
of substance misuse and attitudes towards maternal substance misuse, was rejected (see 
Table 14 for cause of substance misuse and attitudes correlation). 
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Chapter Five:  Conclusion 
Summary of Findings 
Women with prenatal drug misuse need medical care and emotional support at the 
time of delivery of their baby and may be genuinely interested in changing their path in 
life.  Enabling women to break the cycle of substance misuse and care for their babies is 
of benefit to society as it can decrease the financial costs for taxpayers and increase the 
overall health of society (Logan et al., 2013; Patrick et al., 2012; Stein, 2002; Whitman et 
al., 2014).  Healthcare workers have an opportunity to help change a woman’s life 
positively or to reinforce the woman’s negative feelings of self-worth and continuing her 
destructive path.  Increased parental support from healthcare providers is a prime factor 
in improving positive outcomes for the baby, mother (Seattle Children’s, nd), and 
arguably, society.  Consequently, how the healthcare workers feel about working with the 
women and how they treat them, is of utmost importance.   
A common scenario at the birth of a baby is that the medical facility encourages 
the bonding of the new family while teaching baby care skills to the parents as they plan 
for the departure home.  Unfortunately, sometimes the health of the baby may delay the 
release and then parents will receive support and education during the difficult time.  
However, if the parent is perceived negatively or if they feel they are being treated 
negatively, this could alter the traditional training time and the opportunity for positive 
outcomes. Women who are unable to positively bond with their baby can have added 
psychosocial stressors, including increased drug misuse and depression (De Bortoli et al., 
2014; Stein, 2002).  By engaging new mothers and actively including them in the 
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treatment plan for their child, women can gain skills while the babies benefit from the 
parental contact.   
In this study, a practitioner’s comfort in working with women with prenatal 
substance misuse and feelings of empathy for them are indicators of a greater degree of 
positive attitudes. The majority of respondents (60%) indicated feelings of empathy 
towards women with substance misuse with social workers (87%) reporting the highest 
level of empathy among employees.  See to Table 15 for complete list of empathy scores 
by discipline.     
However, this verbalization of empathy may not transcend to an overall reduction 
of stigmatization in the treatment of new mothers.  In this study, a healthcare practitioner 
preferring to not allow a baby to be discharged to a mother with a history of substance 
misuse, a desire to impose greater sanctions on the parent, or allowing less privacy for the 
family, are some indicators of a greater degree of structural stigma.  These characteristics 
demonstrated informal and formal levels of structural stigma, which broadly 
encompasses the policies and the culture within the institution by impacting the mother’s 
ability to utilize all resources/supports (Corrigan, Markowitz, & Watson, 2004; Corrigan 
et al., 2005).  The stigma placed on the women with substance misuse is shown indirectly 
by the fact that 32% of respondents believed that the hospital provides better non-medical 
care than the mothers.  Further, 25% of the respondents reported mothers deserve less 
privacy.  These beliefs are unfortunate as several programs across the country have found 
success in humanizing and empowering women with substance misuse which led to 
decreased hospital length of stay and diminished overall taxpayer costs (Busenbark, 
2016).  This lack of faith in the mother to care for her baby and the invasion of her 
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privacy, are factors that can undermine a mother’s ability to learn and improve her 
parenting skills.  Such actions can deter mothers from seeking follow-up care and 
reinforce a sense of distrust in the healthcare system (Howell & Chasnoff, 1999; Seattle 
Children’s, n.d.).  One survey respondent shared, “There is a big stigma with prenatal 
substance misuse clients.  We as providers tend to only focus on the here and now instead 
of trying to understand what has led to these choices for this client.”  This type of 
thinking is detrimental as often the substance misuse manifests from a combination of 
mental health needs, family addiction, poor social and psychological influences, poor 
coping mechanisms, sexual abuse, and physical abuse (Ngo, n.d.; NIDA, 2014a; Stein, 
2002).   
The initial research question sought to explore not only the respondents’ attitudes 
and whether structural stigma was imposed upon women with prenatal substance misuse, 
but whether this occurrence differed by healthcare discipline and supervision (or 
institutional support).  It was unknown whether the various employment positions might 
reflect different results because of the specific education, training, or experience of such 
disciplines.  Interestingly, discipline did indicate significant differences when reviewing 
attitudes and structural stigma.  Lower scores indicated negative attitudes and higher 
levels of structural stigma towards women with prenatal substance misuse.  As a 
collective group, the respondents reported an overall positive attitude (m=60) yet neutral 
levels of structural stigma (m=34.7) toward women with substance misuse.  Looking at 
the various disciplines, however, Direct Care Nurses had significantly lower scores for 
attitude (m=55) and structural stigma from their counterparts:  Nurse Practitioners 
(m=64.76), Medical Doctors (m=64.8), and Social Workers (m=69.3) (see Table 16 for a 
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complete list of attitude scores by discipline).  Additionally, Direct Nursing Staff on 
average reported having an overall neutral to negative attitude towards women with 
prenatal substance misuse while Medical Doctors, Social Workers, and Nurse 
Practitioners reported an overall neutral to positive attitude.  Higher levels of structural 
stigma were significant between Direct Care Nurses (m=32.7) and support staff 
(m=35.9).  See Table 17 for a complete list of structural stigma scores by discipline. 
Although this study alone cannot determine why disciplines vary, the results are not 
necessarily surprising.  Often Direct Care Nurses spend more direct time working in day-
to-day contact with the mothers and babies affected by prenatal substance misuse which 
may lead to a more stressful work environment or greater levels of burnout, as providers 
feel they are ineffective in changing a mother’s behavior (Stein, 2002).  Though only 9% 
of respondents indicated that they were burned out from working with prenatal substance 
misuse, respondents commented on the stressful environment they often encounter in the 
hospital: 
“NAS and fetal alcohol syndrome often create issues in the NICU because 
these babies are often inconsolable. It often causes distress in NICU 
caregivers as we feel somewhat helpless to aid our patients.”  
 
“Staff have to put up with verbal abuse from families that they are caring 
for. Takes away the joy of caring for patients they have dedicated their 
life’s work.”   
 
“All cases are different; some moms are a lot harder to deal with than 
others.”   
 
If the hope is to improve the situation for women with prenatal substance misuse so that 
they will be more nurturing to their baby and improve their lives, this heightened 
imposition of structural stigma imposed by Direct Care Nurses may be problematic to 
achieving the desired outcome.  This may reflect a need for greater education, especially 
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at the Direct Care Nursing level.  Additional factors that may influence a provider are the 
levels of support perceived and the hospital system cohesiveness.  While level of 
supervision did not yield a significant finding between employment discipline, attitude, 
and structural stigma levels, it is promising that 87% of respondents reported positive 
supervision.  Although 87% viewed the level of supervision as positive, respondents 
shared specific concerns with supervision: 
“Medical upper level staff never exam(sic) these babies. They rely on 
Finnegan scores too much. Nursing leadership does not understand how 
much time the NAS baby needs.”  
 
Supervision is powerful when the relationship is viewed as supportive by the supervisee 
(Frimpong et al., 2011), but such lack of understanding by leadership of these 
comprehensive issues regarding NAS can negatively affect both the practitioner and the 
mother/baby.  Thus, although it is favorable that the healthcare practitioners feel 
supported by their institutions, it is unknown whether the institutions are supporting a 
positive or negative view of the women with prenatal substance misuse.   
Though the overall view of supervision is promising, other factors that can affect 
a healthcare practitioner are the perception of job training/education and the level of 
communication between disciplines.  Of the respondents, 79% reported they received 
adequate education and training for the current position, and 72% reported satisfaction 
with the level of communication between disciplines.  This is promising as research 
indicates increased levels of communication between healthcare practitioners often leads 
to increased job performance and overall health of an organization (Pincus, 1986; Ruck & 
Welch, 2012).  Understanding and recognizing best practice methods in working with 
prenatal substance misuse is a prime factor in increasing positive outcomes (Butler et al., 
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2002; Stein, 2002; Worley, 2014), and possibly may protect against burnout.  Thus, it is 
promising that the majority of respondents reported adequate levels of education and 
training. 
 Beliefs about the cause of maternal substance misuse were also tested.  There 
were strong correlations (r=0.612) between the perceived cause of substance misuse and 
one’s attitude towards prenatal substance misuse. See Table 18 for a complete list of 
perceived causes of substance misuse scores by discipline.  The more favorable attitude 
towards mothers with prenatal substance misuse indicated higher beliefs of disease as a 
cause for substance misuse.  The results indicated that 10% of respondents viewed 
substance misuse as a moral flaw and 41% were unsure if it was a moral flaw.  It is 
concerning that nearly 50% of respondents do not view substance misuse as a medical 
issue.  Healthcare workers operating under the belief that drug misuse is a moral flaw can 
often lead to a punitive and criminal approach for the mother (Stein, 2002).   In fact, 44% 
of staff report more punitive measures should be taken against a mother with substance 
misuse, with an additional 24% unsure.  Respondents reported that 37% believe a mother 
cares more about drugs than her baby, while 16% of respondents were unsure.  
Additionally, 36% believe a mother could quit substance misuse if she wanted to, with 
another 22% unsure if a mother could quit.  Forms of structural stigma increase within 
substance misuse when providers view the individual as refusing to stop their use of drug 
(Corrigan et al., 2009).  Respondents shared many concerns regarding the attitudes and 
beliefs of their colleagues:   
“…I do feel, though, on the unit where I work, there is a lack of 
respect/understanding for mother who have substance abuse/addiction 
problems.” 
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“I think that prenatal substance misuse mothers are judged by medical 
staff.  I believe a large part is due to staff being ignorant of other 
individuals’ background. I wish the atmosphere in the hospital was more 
accepting and loving than judgmental…”  
 
“…Addiction is a real problem and it doesn’t just go away by willing it 
to. I wish they could see addiction as they see any disease so that it can be 
adequately treated.” 
 
Unfortunately, the belief in the cause of substance misuse may impact a healthcare 
practitioner’s ability to provide a supportive, judgement-free experience.  Only 43% of 
respondents believed hospitals provide a supportive place for mothers with substance 
misuse issues.  This is concerning as pregnancy can be an igniting factor for a woman to 
seek substance misuse treatment (Crawford et al., 2015; Marangoni & Felix de Olivera, 
2015; Stein, 2002).  Furthermore, when hospitals adapt a humanistic approach to 
substance misuse, improved outcomes for the baby are more likely to occur (Busenbark, 
2016).  Positively, some providers were able to acknowledge their potential bias but still 
strive to provide the best care, 
“I consider myself experienced in caring for babies with substance 
exposure and their families; however, I still find it hard to overcome my 
own biases and feelings about the situation. I know I will never be able to 
fully understand how a mother with substance use disorder 
feels/acts/thinks, given that I have never used a substance, have never 
experienced major trauma in my life, etc. By talking to these moms on a 
personal level and asking the hard questions without judgement, I feel like 
I am getting closer to providing the most compassionate care I can.” 
 
By recognizing one’s own biases, the healthcare worker is then better able to work 
through his/her personal feelings and provide the most effective care for the mother and 
baby. 
The overall findings indicate that, although there are some positive attitudes 
towards mothers with prenatal drug misuse, negative structural stigma exists across all 
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disciplines.  The pervasive nonadherence to the disease model (51%) of drug misuse, 
may, in part, be responsible for this situation.  This mindset may negatively impact 
patient care by creating an increased hostile environment and lack of support for the 
family.   
There is also an indication that the healthcare provider’s discipline may influence 
their attitudes and levels of structural stigma.  This may, in part, be due to the type of 
discipline and general teachings within each area, as well as, the potential effects of 
working directly with the population.  However, further research is needed to examine 
directly why different healthcare disciplines vary in their attitudes and stigma level 
toward prenatal substance misuse.  The potential lack of modeling behavior at the higher 
employment levels may also impact the implementation of non-stigmatizing behavior.  
Although respondents reported adequate supervision, future research to assess the type of 
supervision and what behavior is being supported, as well as knowing the model of 
addiction to which the supervisors and leadership ascribe, would be interesting.  Such 
information may lead to additional understanding of the hospital systems beliefs in total. 
Limitations 
The research study had some limitations that may have affected the results.  The 
first is the use of a convenience sample of healthcare practitioners from a central Indiana 
hospital system.  The hospital was not randomly selected and not representative of the 
general population of healthcare practitioners as the sample was overwhelmingly female 
(94%) and Caucasian (92%).  Additionally, not all disciplines were able to be adequately 
included.  Such disciplines absent in the sample include:  obstetrics, chaplains, dieticians, 
and ancillary workers.  Direct Care Nurses were the most represented group (41%).  It is 
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not shocking that nursing had a higher presence, as more nurses are employed over the 
other disciplines. However, the other disciplines were not adequately represented.  More 
hospitals will need to be included to gain a greater sample of ancillary departments like 
lactation consultants, chaplains, administration, etc.  There are no current studies 
examining provider attitudes and stigma levels across disciplines, yet, all have unique 
perspectives which may affect the results.   
An additional limitation relates to the use of a new survey instrument.  While 
reliability for the scales demonstrated at least an acceptable degree of reliability, 
additional testing and scale adaptions may yield greater reliability.  The single survey 
item questions like:  burnout and supervision satisfaction, among others, may not have 
been able to account for the full scope of other variables that impact attitudes and stigma 
levels.  Additionally, the effect size for employment disciplines (0.142) and level of 
supervision (.058) was small, which was concerning as it posed a challenge in estimating 
the true relationship between variables.  However, the power for employment discipline 
(.987) was well within the appropriate range.   
There is a lack of prior research exploring practitioner structural stigma and 
attitudes of prenatal substance misuse across hospital disciplines.  Thus, this research is 
exploratory in nature and cannot be taken as explanatory.  Additionally, response bias 
may also have affected the results.  Respondents may have felt a need to report more 
positive attitudes, potentially skewing results.  The overall quantitative nature of the 
study limited respondents from expressing additional details, concerns, and attitudes.  By 
following up with additional qualitative research, greater understanding and themes may 
develop.    
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Implications for Future Research 
 Understanding the effects of prenatal drug use on healthcare practitioners offers 
implications for education, policy, research, and clinical practice.  Drug use in pregnancy 
is a public health concern (Stone, 2015), and this research study indicates that healthcare 
practitioners’ beliefs and attitudes may negatively affect a mother’s hospital experience.  
As hospitals are at times the front-line defense for substance misuse, creating a 
supportive environment for both staff and mother, the needs of the mother and baby will 
likely be met with increased effectiveness.  Creating a supportive environment is 
necessary for the mother but also for the practitioner.  A supportive environment for the 
practitioner may include additional peer support when working with a baby experiencing 
NAS, as often such babies are inconsolable and irritable (Chasnoff et al., 1987).  This 
likely includes upper management being educated and offered the resources needed for 
the practitioner to promote insight as to the needs of the baby and healthcare practitioner.  
Additional research is needed to address hospital policies and the implications of those 
policies.  By examining specific policies, procedures, and protocols, like the use of 
education and support for staff, a greater understanding of potential structural stigmas 
may emerge.  Beyond the formal policies, investigating the potential of informal stigmas 
adopted by the hospital system may lead to a better understanding of possible 
improvements and educational opportunities.  Further research to explore what 
practitioners would like to change in the hospital, including support, policy, and practice 
initiatives may lead to better services for patients but also decrease potential burnout and 
negative attitudes.  Such research can better assess the levels of burnout staff may be 
experiencing.   
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 A major area for further research and education implementation is understanding 
the causes of substance misuse.  With more than 50% of respondents not reporting drug 
misuse as a medical issue, greater education for practitioners is needed to help explore 
the cause and perpetuation of substance misuse.  With greater education and 
understanding of the causes of substance misuse, improved policy and practice models 
can emerge, which could lead to healthier outcomes for mothers, babies, and healthcare 
relationships. 
Also, this study examined the attitudes and stigma levels of the healthcare 
practitioners and not the perceptions of families.  Perceptions of the family may yield 
different results regarding structural stigma levels within the healthcare field.  By 
conducting research with both healthcare practitioners and women struggling with 
prenatal substance misuse, a greater understanding of the experiences for all parties can 
be achieved.  Additionally, more comprehensive programming for healthcare 
practitioners and families can be instituted. 
Policy Recommendations 
To assist in improving the attitudes and stigma levels of providers within a 
hospital environment, policy recommendations and an action protocol are derived from 
this research.  Ultimately, a three-tiered policy and practice protocol emerged.  Phase 1 is 
the Education Protocol.  The objective is to promote a hospital culture of support and 
education for employees, across disciplines, working with NAS.  First, regular (yearly) 
dissemination of the Attitudes, Stigma, and Causation Tool is completed by all 
employees.  The tool is a modified version of the survey used in this study.  Only the 
attitude, stigma, and causation scales remain.  Next, if an employee scores within the 
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Extremely Negative to Neutral categories, they are then referred for increased education 
and support.  Increased education focuses on the causes of substance misuse, the supports 
available to mothers, and understanding the ramifications of one’s own attitudes and 
stigma towards a mother with substance misuse.  The education is provided by the social 
workers and leadership who have advanced training in maternal substance misuse.  
Support is equally important to increased education.  The individual will have support 
from their supervisor and be allowed to receive and offer feedback as to their own needs 
when working with NAS.  If the individual scores within the Positive categories, then 
they are referred to the support section.  Receiving continued support and being 
encouraged to offer feedback within their work environment will help continue the 
positive attitude.  The tool allows the leadership team to be aware of the climate within 
the hospital and for employees to have increased self-awareness and opportunity for 
education.  As the protocol is intended for yearly dissemination, the hospital system will 
have a baseline for the current climate among their employees.  The concerns cannot be 
improved or changed when one does not know the actual problems, issues, and 
challenges. 
 Phase 2, Prenatal Substance Misuse Inclusive Services Protocol, is the next step.  
The objective for Phase 2 is to promote an inclusive, supportive, and safe environment 
for mothers and caregivers with babies experiencing NAS (see Figure 1).  First, the 
policy should enforce that mothers be allowed or encouraged to stay crib side with the 
baby. Often this is called “rooming-in.”  Rooming-in will increase parent interaction and 
allow staff to train and gain better insight to the parent’s ability and needs.  Secondly, 
when the baby is medically stable, the mother is able to provide the majority of feeds for 
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the baby, give medication as appropriate, change diapers and clothes, and bathe the baby.  
Social workers will follow and support the family a minimum of three times per week.  
Social workers can then identify strengths, barriers, and needs of the mother.  Social 
work will meet with the Department of Child Services to assist with wrap around 
services.  Additionally, the protocol requires weekly supervision for all employees 
working with mothers and babies with NAS.  By recognizing an NAS specific policy for 
all employees, the expectations and culture of the hospital can begin to shift to a more 
positive framework. 
 Lastly, Phase 3, Expectations and Engagement Protocol, allows for 
documentation of both mother and employee when caring for the baby (see Figure 2).  
The parent will document the day, time, service provided, and their current comfort level 
with the service.  The parent will complete the form for every action. The parent should 
be encouraged to decide their comfort level using a numerical scale, facial scale, or free 
text. This is necessary as mothers will have different abilities to explain comfort.  Next, 
the staff will complete the same form with the added section to state the supports the staff 
offered.  This allows staff to specifically identify concerns and increase accountability for 
staff to engage with the mother and provide support by decreasing the acceptance that the 
“mother is not able to do it,” despite a lack of education or support by staff.   
 By incorporating the three Phase Protocol, a follow-up study can then be 
completed to assess if the system can improve the hospital culture and improve services 
for mothers.  This evidence-based research can support the Protecting Our Infants Act of 
2015. 
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Overall, further research is necessary to better understand how the families view 
the healthcare system and their experiences within the maternal/fetal care setting.  By 
recognizing the unique experiences of the families, specific needs and concerns can then 
be identified.  Staff may believe they are supporting an individual, but if the support they 
are offering is not the type needed, it may deter a mother’s desire to receive help from 
healthcare providers.  Such feelings can diminish the potential for outreach prior to and 
after delivery.  By creating policy change, increasing education, and continuing research, 
social workers have an opportunity to develop responsive outreach programs for women 
struggling with substance misuse.   
Concluding Remarks 
 Prenatal substance misuse, which is found in 5% of all pregnancies, affects not 
only the health of the baby but has implications for the mothers, healthcare practitioners, 
and the community at large (NIDA, 2017).  At a minimum, mothers face legal 
ramifications, concerns for parent/child bonding, negative provider attitudes, and stigma.  
Meanwhile, healthcare practitioners face stressful work environments as extensive care 
must be provided to the affected babies and due to working in a situation that is 
potentially antithetical to the practitioner’s belief system.  The initial contact of the 
mother with the healthcare providers could grossly affect how the mother will ultimately 
care for herself and her baby.  If the drug misuse during pregnancy is perceived so 
negatively by the healthcare practitioner, the care provided potentially becomes 
compromised.   
Understanding the needs of the mother and the healthcare worker ultimately 
affects society.  Lastly, the community faces high financial costs due to lengthy hospital 
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admissions and ongoing supports needed for the baby.  Yet, there is a dearth of literature 
investigating prenatal substance misuse stigma and attitudes across healthcare disciplines.  
This study provided a better understanding of healthcare practitioners’ attitudes and 
levels of structural stigma within the maternal/fetal healthcare setting.  Continued 
research is imperative to ensure best practice and provider support.  Hospital staff, at 
times, are the first interaction a mother has to help her through her substance misuse.  The 
mother, baby, and community at large deserve us to work towards an open and conducive 
experience.  Substance misuse is not slowing down, but with proper policies, practice, 
support, and outreach, mothers and their babies can be better served. 
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Chapter Six:  Tables and Figures 
Table 1:  Hypotheses, Variables, and Statistical Tests 
 
 
Hypotheses 
 
IV 
 
DV 
 
Statistical 
Test 
    
H1:  The area of 
employment practice and 
level of supervision will be 
predictive of healthcare 
providers’ attitudes and 
level of structural stigma 
towards women with 
prenatal substance misuse. 
Area of practice 
 
Level of 
supervision 
Structural 
Stigma Scale 
  
Attitudes of 
Healthcare 
Practitioner 
Scale 
MANOVA 
    
H2:  Healthcare providers’ 
expressed statement of their 
belief of causation of 
substance misuse will be 
predictive of their attitudes 
towards women with 
prenatal substance misuse 
Expressed 
statement of 
causation of 
addiction 
Attitude toward 
women with 
prenatal 
substance 
misuse 
Correlation 
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Table 2:  Hypotheses, Variables, and Survey Items 
 
Hypothesis Scale/Variable Survey 
Items 
Reverse-
Coded 
H1:  The area of employment practice and level 
of supervision will be predictive of healthcare 
providers’ attitudes and level of structural stigma 
towards women with prenatal substance misuse. 
Provider 
Attitudes  
Q13-
Q28, 
Q40, 
Q47 
Q47 
Provider 
Structural 
Stigma 
Q32, 
Q35, 
Q36, 
Q47, 
Q48, 
Q49, 
Q50, 
Q51, 
Q53, 
Q54, 
Q55 
 
Q32, Q35, 
Q36, Q53 
Area of Practice Q4  
Level of 
Supervision 
Q31  
H2:  Healthcare providers’ expressed statement of 
their belief of causation of substance misuse will 
be predictive of their attitudes towards women 
with prenatal substance misuse 
Belief of 
Causation 
Q41, 
Q42, 
Q43, 
Q44, 
Q45 
Q41 
Provider 
Attitudes  
Q13-
Q28, 
Q40, 
Q47 
Q47 
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Table 3:  Employment Disciplines 
 
Employment  
Discipline 
Original 
n/% 
 Employment 
Discipline 
Consolidated   
n/% 
MD-Direct 
 
17 (12.6%)  Medical Doctor  18 (13.3%) 
MD-Admin 
 
1 (0.7%)  Administration 5 (3.7%) 
Administration 
 
1 (0.7%)  Direct Care 
Nursing 
52 (38.5%) 
Direct Care 
Nursing 
 
52 (38.5%)  Nurse 
Practitioner/PA 
18 (13.3%) 
Nurse 
Practitioner/PA 
 
16 (11.9%)  Social Work 17 (12.6%) 
Case Manager 
 
4 (3.0%)  Support Staff 17 (12.6%) 
Nursing 
Management 
 
3 (2.2%)    
Social Work 
 
17 (12.6%)    
Respiratory 
Therapist 
 
6 (4.4%)    
Music Therapist 
 
1 (0.7%)    
Lactation 
Consultant 
   
2 (1.5%)    
Pharmacy 
 
1 (0.7%)    
Other 
 
6 (4.4%)    
 7
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Table 4:  Inter-Item Correlation, Attitudes Scale 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Hard to like 
cigarette smokers 
1 .437 .703 .399 .638 .398 .636 .434 .650 .467 .643 .487 .653 .482 .676 .491 .378 .379 
Uncomfortable 
working with 
cigarette smokers 
 1 .381 .582 .329 .529 .337 .533 .411 .661 .355 .586 .367 .601 .375 .605 .294 .227 
Hard to like 
pregnant problem 
drinkers 
  1 .568 .757 .420 .775 .469 .698 .427 .798 .498 .750 .522 .607 .465 .377 .440 
Uncomfortable 
working with 
pregnant problem 
drinkers 
   1 .484 .706 .514 .752 .436 .668 .521 .732 .463 .734 .363 .704 .355 .367 
Hard to like 
pregnant heroin 
users 
    1 .529 .969 .526 .679 .445 .953 .548 .885 .563 .698 .504 .248 .467 
Uncomfortable 
working with 
pregnant heroin 
users 
     1 .526 .929 .513 .757 .519 .922 .491 .872 .523 .828 .338 .521 
Hard to like 
pregnant cocaine 
users 
      1 .561 .704 .455 .972 .563 .880 .572 .689 .513 .313 .460 
Uncomfortable 
working with 
pregnant cocaine 
users 
       1 .519 .752 .547 .938 .492 .883 .503 .839 .356 .490 
Hard to like 
pregnant marijuana 
users 
        1 .623 .717 .530 .689 .547 .672 .539 .456 .374 
Uncomfortable 
working with 
pregnant marijuana 
users 
         1 .459 .774 .453 .766 .488 .749 .405 .328 
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Table 4:  Inter-Item Correlation, Attitudes Scale (continued) 
 1 2 3 4 5 6 7 8 9 010 11 12 13 14 15 16 17 18 
Hard to like 
pregnant 
methamphetamine 
users 
          1 .569 .894 .575 .700 .520 .306 .452 
Uncomfortable 
working with 
pregnant 
methamphetamine 
users 
           1 .526 .927 .562 .867 .364 .457 
Hard to like 
pregnant opioid 
users 
            1 .612 .760 .575 .282 .459 
Uncomfortable 
working with 
pregnant opioid 
users 
             1 .592 .895 .357 .483 
Hard to like 
pregnant Subxone… 
users 
              1 .656 .393 .423 
Uncomfortable 
working with 
pregnant Subxone… 
users 
               1 .379 .434 
Burned out working 
with mothers and 
babies with drug 
use/exposure 
                1 .192 
Empathy for a 
pregnant/postpartum 
woman with 
substance misuse 
                 1 
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Table 5:  Inter-Item Correlation Matrix for Structural Stigmas 
 
 1 2 3 4 5 6 7 8 9 10 11 
Comfortable with the discharge plan 
for a child with drug exposure. 
1 .146 .058 .751 .247 .164 .310 .262 .142 .338 .158 
Satisfied with level of community 
support for pregnant substance 
misuse. 
 1 -.108 .209 -.055 -.033 -.211 -.085 -.032 -.184 -.137 
Go out of way to work with a mother 
or baby with drug use/exposure. 
  1 -.062 .418 .445 .189 .193 .159 .261 .370 
Comfortable with the discharge plan 
for a mother with substance misuse. 
   1 .109 .012 .188 .183 .099 .263 .099 
Prefer not to work with babies with 
drug exposure. 
    1 .622 .106 .206 .067 .259 .257 
Prefer not to work with pregnant 
women with substance misuse. 
     1 .179 .180 .180 .209 .282 
Hospital should impose greater 
sanctions on a mother with substance 
misuse during p... 
      1 .320 .328 .490 .446 
Not comfortable leaving a child in a 
room with their substance misusing 
parent. 
       1 .219 .420 .160 
Should be regularly drug tested.         1 .195 .276 
Infant should never discharge with 
the mother. 
         1 .407 
Deserve less privacy.           1 
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Table 6:  General Beliefs and Attitudes 
 
QUESTION 
n=117 
STRONGLY 
AGREE 
AGREE UNDECIDED DISAGREE STRONGLY 
DISAGREE 
Believe hospital staff can provide better, non-
medical care 
8 (6.8%) 30 (25.6%) 44(37.6%) 28 (23.9%) 7 (6.0%) 
State should impose greater sanctions on a 
mother with substance misuse during preg... 
14 (12.0%) 44 (37.6%) 33 (28.2%) 15 (12.8%) 11 (9.4%) 
Schooling prepared me to discuss health risk 
behaviors with patients 
18 (15.1%) 62 (52.1%) 13 (10.9%) 24 (20.2%) 2 (1.7%) 
Satisfied with the level of communication 
between disciplines 
23 (19.3%) 63 (52.9%) 14 (11.8%) 17 (14.3%) 2 (1.7%) 
Organization provides a supportive environment 
for mothers 
12 (10.1%) 40 (33.6%) 41 (34.5%) 26 (21.8%) 0 (0%) 
Believe more punitive measures should be taken 
against 
11 (9.4%) 40 (34.2%) 33 (28.2%) 21 (17.9%) 12 (10.3%) 
Burned out working with mothers and babies 
with drug use/exposure 
1 (0.9%) 9 (7.7%) 11 (9.4%) 82 (70.1%) 14 (12.0%) 
Person could quit illicit drug use if they really 
wanted to 
3 (2.6%) 39 (33.3%) 26 (22.2%) 35 (29.9%) 14 (12.0%) 
Person who uses illicit drugs during pregnancy 
cares more about drugs than the baby 
7 (6.0%) 36 (30.8%) 19 (16.2%) 44 (37.6%) 11 (9.4%) 
Empathy for a pregnant/post-partum woman 
with substance misuse 
14 (12.0%) 68 (58.1%) 25 (21.4%) 10 (8.5%)  0 (0%) 
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Table 7:  Correlation of Stigma and Attitudes 
 Attitudes Scale P 
Stigma .602** .000 
Correlation is significant at the 0.01 level (2 tailed) 
 
 
 
Table 8:  Box’s M Test of Equality of Covariance Matrices 
 
 
Box’s 
M 
 
44.633 
 
F (0.876) 
 
df1=39 
 
Df2=1480.015 
 
p>0.688 
 
 
 
Table 9:  Inter-Item Correlation Causation Matrix 
 
 1 2 3 4 5 
Believe addiction is a medical 
condition. 
 
1.000 .357 .346 .280 .466 
Believe addiction is caused  
  by a moral flaw. 
 
 1.000 .391 .397 .467 
Believe addiction is selfish. 
 
  1.000 .508 .527 
Person could quit illicit drug use  
  if they really wanted to. 
 
   1.000 .641 
Person who uses illicit drugs during  
  pregnancy cares more about  
  drugs than the baby. 
    1.000 
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Table 10:  General Demographics of Respondents 
 
Demographic 
Characteristics 
N % 
Race   
 American Indian or Alaska  
 Native 
1 .8 
 Black or African American 6 4.7 
 Asian 3 2.4 
 White/ Caucasian 117 92.1 
   
Ethnicity   
 Hispanic or Latino 3 2.4 
 Not Hispanic or Latino 124 97.6 
   
Gender-Identify   
 Female 117 93.6 
 Male 8 6.4 
   
Currently working with mother with 
substance misuse or affected baby 
  
 Yes 110 86.6 
 No 17 13.4 
   
Percentage of work week in direct 
contact 
  
 0-25% 63 49.6 
 26-50% 39 30.7 
 51-75% 16 12.6 
 76-100% 9 7.1 
   
Practiced in Healthcare Field   
 0-4 years 33 26.0 
 5-9 years 24 18.9 
 10-14 years 22 17.3 
 15-19 years 13 10.2 
 20-24 years 8 6.3 
 25+ years 27 21.3 
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Table 11:  MANOVA-Difference in Attitudes and Stigma for Employment 
Disciplines and Supervision Level 
 
Variable Pillai’s 
Trace 
F Hypothesis 
df 
Err 
df 
P Partial 
Eta 
Squared 
Observed 
Power 
Employment 
Discipline 
0.281 3.243 10 198 .001* .141 .987 
Supervision 0.116 2.039 6 198 .062 .058 .732 
Employment  
Discipline* 
Supervision 
0.211 1.295 18 198 .194 .105 .837 
Statistically significant difference:  p<0 .05* 
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Table 12:  Post-Hoc Analysis Test for Factorial MANOVA 
 
Dependent 
Variable 
Current 
Employment 
Discipline 
 Mean 
Difference 
SD P 
Attitude 
Scale 
MD Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Social Worker 
Support Staff 
-.70 
9.80 
-.14 
-4.58 
8.61 
7.777 
4.078 
4.895 
4.967 
4.967 
1.00 
.165 
1.00 
.940 
-.513 
 Administration Medical Doctor 
Direct Care 
Nurse 
Nurse 
Practitioner 
Social Worker 
Support Staff 
.70 
10.50 
.56 
-3.88 
9.31 
7.777 
7.186 
7.680 
7.725 
7.725 
1.00 
.690 
1.00 
.996 
.833 
 Direct Care 
Nurse 
Medical Doctor 
Administration 
Nurse 
Practitioner/PA 
Social Worker 
Support Staff 
-9.80 
-10.50 
-9.94 
-14.37 
-1.19 
4.078 
7.186 
3.890 
3.979 
3.979 
.165 
.690 
.118 
.006* 
1.00 
 Nurse 
Practitioner 
Medical Doctor 
Administration 
Direct Care 
Nurse 
Social Worker 
Support Staff 
.14 
-.56 
9.94 
-4.43 
8.75 
4.895 
7.680 
3.890 
4.814 
4.814 
1.00 
1.00 
.268 
.973 
.654 
 Social Worker Medical Doctor 
Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Support Staff 
4.58 
3.88 
14.37 
4.43 
13.19 
4.967 
7.725 
3.979 
4.814 
4.866 
.973 
.988 
.029* 
.973 
.211 
 Support Staff Medical Doctor 
Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Social Worker 
-8.61 
-9.31 
1.19 
-8.75 
-13.19 
4.967 
7.725 
3.979 
4.814 
4.886 
.699 
.917 
1.00 
.654 
.211 
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Stigma MD Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Social Worker 
Support Staff 
3.47 
3.73 
-.18 
.28 
.53 
2.676 
1.403 
1.685 
1.709 
1.709 
.787 
.093 
1.00 
1.00 
1.00 
 Administration Medical Doctor 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Social Worker 
Support Staff 
-3.47 
.27 
-3.65 
-3.19 
-2.94 
2.676 
2.473 
2.643 
2.658 
2.658 
.787 
1.00 
.739 
.836 
.878 
 Direct Care 
Nurse 
 
Medical Doctor 
Administration 
Nurse 
Practitioner/PA 
Social Worker 
Support Staff 
-3.73 
-.27 
-3.91 
-3.45 
-3.20 
1.403 
2.473 
1.339 
1.369 
1.369 
.098 
1.00 
.048* 
.128 
.189 
 Nurse 
Practitioner/PA 
Medical Doctor 
Administration 
Direct Care 
Nurse 
Social Worker 
Support Staff  
.18 
3.65 
3.91 
.46 
.71 
1.685 
2.643 
1.339 
1.656 
1.656 
1.00 
.739 
.048* 
1.00 
.998 
 Social Worker Medical Doctor 
Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA 
Support Staff 
-.28 
3.19 
3.45 
-.46 
.25 
1.709 
2.658 
1.369 
1.656 
1.681 
1.00 
.836 
.128 
1.00 
1.00 
 Support Staff Medical Doctor 
Administration 
Direct Care 
Nurse 
Nurse 
Practitioner/PA  
Social Worker  
-.53 
2.94 
3.20 
-.71 
-.25 
1.709 
2.658 
1.369 
1.656 
-.25 
1.00 
.878 
.189 
.998 
1.00 
p<0.05* 
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Table 13:  Multivariate Means 
 
Attitudes Scale Role Supervision Mean(SD) 
 Medical Doctor Strongly Agree 
Agree 
66.67 (17.5) 
62.00 (11.3) 
 Administration Strongly Agree 
Agree 
64.00 (22.9) 
70.00 (-) 
 Direct Care Nurse Strongly Agree 
Agree 
Undecided 
Disagree 
57.33 (17.44) 
56.00 (12.62) 
32.00 (11.31) 
39 (-) 
 Nurse Practitioner/PA Strongly Agree 
Agree 
Undecided 
71.33 (20.11) 
65.15 (10.77) 
40 (-) 
 Social Worker Strongly Agree 
Agree 
Undecided 
73.4 (10.09) 
65.67 (5.16) 
69.80 (15.35) 
 Support Staff Strongly Agree 
Agree 
Undecided 
Disagree 
59.25 (16.52) 
49.17 (12.48) 
56.00 (18.08) 
66.33 (7.64) 
Stigma Scale Medical Doctor Strongly Agree 
Agree 
37.67 (5.22) 
34.67 (3.45) 
 Administration Strongly Agree 
Agree 
32.33 (10.50) 
35 (-) 
 Direct Care Nurse Strongly Agree 
Agree 
Undecided 
Disagree 
33.33 (5.31) 
32.88 (4.15) 
32.50 (2.12) 
21 (-) 
 Nurse Practitioner/PA Strongly Agree 
Agree 
Undecided 
35.67 (4.619) 
37.54 (4.52) 
28 (-) 
 Social Worker Strongly Agree 
Agree 
Undecided 
35.60 (3.44) 
34.67 (3.98) 
38.60 (5.94) 
 Support Staff Strongly Agree 
Agree 
Undecided 
Disagree 
39.00 (5.35) 
34.33 (5.13) 
34.67 (2.89) 
36.33 (5.86) 
Attitudes Scale (F(10,198)=4.63, p=.001, դ2=0.189) 
Stigma levels (F(6,198)=2.64, p < .05, դ2=0.118) 
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Table 14:  Correlation-Causation of Substance Misuse 
 
 Attitudes Scale P 
Causation of Use .612** .000 
Correlation is significant at the 0.01 level (2 tailed) 
 
 
Table 15:  Empathy Score by Discipline 
 
POSITION STRONGLY 
DISAGREE 
DISAGREE NEUTRAL AGREE STRONGLY 
AGREE 
MD-All 
  (n=15) 
 
0 (0%) 0 (0%) 2 (13.33%) 9 (60.00%) 4 (26.67%) 
Administration 
  (n=4) 
 
0 (0%) 1 (25.00%) 1 (25.00%) 1 (25.00%) 1 (25.00%) 
Direct Care 
Nursing 
  (n=49) 
 
0 (0%) 6 (12.24%) 13 
(26.53%) 
30 
(61.22%) 
0 (0%) 
NP/PA 
  (n=17) 
  
0 (0%) 2 (11.76%) 2 (11.76%) 11 
(64.71%) 
2 (11.76%) 
Social Work 
  (n=16) 
 
0 (0%) 0 (0%) 2 (12.50%) 10 
(62.50%) 
4 (25.00%) 
Support Staff 
  (n=16) 
 
0 (0%) 1 (6.25%) 5 (31.25%) 7 (43.75%) 3 (18.75%) 
Total 
  (n=117) 
0 (0%) 10 (8.55%) 25 
(21.37%) 
68 
(58.12%) 
14 
(11.97%) 
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Table 16:  Overall Attitudes by Employment Discipline  
POSITION  EXTREMELY 
NEGATIVE 
NEGATIVE 
 
NEUTRAL 
 
POSITIVE 
 
EXTREMELY 
POSITIVE 
 
MD-Direct  (n =14) 
1 (7.14%) 1 (7.14%) 5 (35.71%) 5 (35.71%) 2 (14.29%) 
MD-Admin  (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Direct Care Nursing  (n=49) 
7 (14.29%) 10 (20.41%) 21 (42.86%) 10 (20.41%) 1 (2.04%) 
NP/PA   (n=17) 
0 (0%) 3 (17.65%) 6 (35.29%) 6 (35.29%) 2 (11.76%) 
Case Manager  (n=4) 
0 (0%) 3 (75.00%) 0 (0%) 1 (25%) 0 (0%) 
Nursing Management  (n=3) 
0 (0%) 1 (33.33%) 1 (33.33%) 1 (33.33%) 0 (0%) 
Social Work  (n=16) 
0 (0%) 1 (6.25%) 8 (50.00%) 5 (31.25%) 2 (12.50%) 
Respiratory Therapist  (n=5) 
0 (0%) 4 (80.00%) 1 (20.00%) 0 (0%) 0 (0%) 
Music Therapist (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Lactation Consultant  (n=2) 
0 (0%) 0 (0%) 1 (50.00%) 1 (50.00%) 0 (0%) 
Nursing Educator  (n=1) 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (100%) 
Pharmacy  (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Non Clinical  (n=3) 
0 (0%) 0 (0%) 1 (33.33%) 2 (66.67) 0 (0%) 
Total    (n=117) 
8 (6.84%) 23 (19.66%) 44 (37.61%) 34 (29.06%) 8 (6.84%) 
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Table 17:  Overall Stigma Level by Discipline 
POSITION EXTREMELY 
NEGATIVE 
NEGATIVE 
 
NEUTRAL 
 
POSITIVE 
 
EXTREMELY 
POSITIVE 
MD-Direct  (n =14) 
0 (0%) 0 (0%) 9 (64.29%) 5 (35.71%) 0 (0%) 
MD-Admin  (n=1) 
0 (0%) 0 (0%) 1 (100%) 0 (0%) 0 (0%) 
Direct Care Nursing  (n=49) 
0 (0%) 11 (22.45%) 31 (63.27%) 7 (14.29%) 0 (0%) 
NP/PA  (n=17) 
0 (0%) 1 (5.88%) 8 (47.06) 8 (47.06%) 0 (0%) 
Case Manager  (n=4) 
0 (0%) 1 (25.00%) 2 (50.00%) 1 (25.00%) 0 (0%) 
Nursing Management  (n=3) 
0 (0%) 1 (33.33%) 2 (66.67%) 0 (0%) 0 (0%) 
Social Work  (n=16) 
0 (0%) 0 (0%) 12 (75.00%) 4 (25.0%) 0 (0%) 
Respiratory Therapist  (n=5) 
0 (0%) 1 (20.00%) 3 (60.00%) 1 (20.0%) 0 (0%) 
Music Therapist  (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Lactation Consultant  (n=2) 
0 (0%) 0 (0%) 2 (100%) 0 (0%) 0 (0%) 
Nursing Educator  (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Pharmacy  (n=1) 
0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
Non Clinical  (n=3) 
0 (0%) 0 (0%) 1 (33.33%) 2 (66.67%) 0 (0%) 
Total  (n=117) 
0 (0%) 15 (12.82%) 71 (60.68%) 31 (26.50% 0 (0%) 
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Table 18:  Causation of Substance Misuse by Employment Discipline 
POSITION HIGHLY MORAL 
FLAW 
 
MORAL FLAW 
 
 
NEUTRAL 
 
 
DISEASE 
 
 
HIGHLY DISEASE 
 
MD-All   (n=15) 
0 (0%) 0 (0%) 4 (26.67%) 8 (53.33%) 3 (20.00%) 
Administration  (n=4) 
0 (0%) 
1 (25.0%) 
1 (25.00%) 2 (50.00%) 0 (0%) 
Direct Care Nursing  (n=49) 
0 (0%) 8 (16.33%) 28 (57.14%) 11 (22.45%) 2 (4.08%) 
NP/PA  (n=17)  
0 (0%) 1 (5.88%) 4 (23.53%) 9 (52.94%) 3 (17.65%) 
Social Work  (n=16) 
0 (0%) 0 (0%) 1 (6.25%) 9 (56.25%) 6 (37.50) 
Support Staff  (n=16) 
0 (0%) 2 (12.50%) 10 (62.50%) 2 (12.50%) 2 (12.50%) 
Total  (n=117) 
0 (0%) 12 (10.26%) 48 (41.03%) 41 (35.04%) 16 (13.68%) 
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Figure 1:  Education Protocol 
Objective:  To promote a hospital culture of support and education for employees, across 
disciplines, working with NAS. 
 
 
 
 
  
Regular (yearly) Dissemination of Attitudes, 
Stigma, and Causation Tool 
Scores Extremely 
Negative to Neutral
Increased Education
Cause of Substance 
Misuse
Supports Available to 
Mothers
Ramifications
Support
Feedback
Scores Positive +
Support
Feedback
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Figure 2:  Expectation and Engagement Protocol 
Caregiver 
Caregiver Day Time Services Comfort Level 
Mother   Bath 2/5 
Father   Bottle Feed  
Mother   Diaper Change I was scared, It 
was hard, I feel 
good… 
 
Staff 
Caregiver Day Time Services Comfort 
Level 
Support 
Offered 
Provider 
Mother   Bath 2.5 Education; 
Verbal praise 
KET 
Mother   Bottle 
Feed 
4/5 Demonstrated 
Feed 
KET 
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Appendix A:  Invitation to Participate (institution) 
 
Greetings, 
I am writing to request your institution’s participation in an important research study 
aimed at discovering new information about the effects on healthcare providers whom 
work with prenatal substance misuse. The information is important for many reasons. 
Drug use during pregnancy is a public health crisis.  Healthcare providers face highly 
stressful work situations. More needs to be done to support healthcare providers and 
exploring the attitudes and perceptions of healthcare providers may offer insight to aid 
those in the workforce and the families affected by prenatal substance misuse. In 
addition, this project will provide information that may inform the way healthcare 
institutions approach prenatal substance misuse. 
 
Data collection will consist of an internet-based survey, eliciting no identifying 
information. The goal is for the survey to be distributed to all employees, across 
disciplines (I.e. neonatologist, nursing, social work, chaplains, 
physical/occupational/speech therapy, dietary, lactation consultants, respiratory 
therapists, interpreters, management, HROB, family care, specialty departments, etc.). 
The survey will be available to be sent as a link on the hospital e-mail distribution list 
serve. The research study will undergo rigorous review through a panel of doctoral level 
researchers as well as the Indiana University IRB.  
 
Participation in the study is voluntary and participants may stop at any time. I will not 
have employee personal information and will not contact them for further information.  
If you have any questions about this survey, please contact Kristin Trainor.  Thank for 
your commitment to the healthcare profession and for your consideration to participate.  
Respectfully,  
Kristin Trainor, MSW, LCSW 
Indiana University School of Social Work 
902 W New York Street ES 4138 
Indianapolis, Indiana 
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Appendix B:  Invitation to Participate (individual) 
 
 
 
Greetings Healthcare Providers, 
 
I am writing to request your participation in an important research study aimed at 
discovering new information about the effects on healthcare providers who work with 
prenatal substance misuse. The information is important for many reasons. Drug use 
during pregnancy is a public health crisis.  Healthcare providers face highly stressful 
work situations. More needs to be done to support healthcare providers and exploring the 
attitudes and perceptions of healthcare providers may offer insight to aid those in the 
workforce and the families affected by prenatal substance misuse. In addition, this project 
will provide information that may inform the way healthcare institutions approach 
prenatal substance misuse. This study is called Prenatal Substance Misuse Attitudes and 
Perceptions. This web-based study should take 10-15 minutes to complete. I would 
appreciate it greatly if you would complete the survey. 
Participation in the study is voluntary and you may stop at any time.  You are receiving 
this e-mail through your employer’s listserv. I do not have your personal information and 
will not contact you for further information. I will not know who took the survey and 
who did not.  
If you have any questions about this survey, please contact Kristin Trainor.  In addition, 
more information about the study can be found by reading the study information sheet on 
the first page of the survey. 
If you would like to participate, please click on the following link: 
I look forward to your participation and am thankful for your commitment to the 
healthcare profession.  
 
Respectfully, 
Kristin Trainor, MSW, LCSW 
Indiana University School of Social Work 
902 W New York Street ES 4138 
Indianapolis, Indiana 
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Appendix C:  Study Timeframe Letter 
 
Greetings! 
I would like to take the opportunity to thank you for your support in the Prenatal 
Substance Misuse Attitudes and Perceptions study.  I greatly appreciate the time that your 
institution has spent forwarding the survey to your associates.  I will begin data analysis 
on ________.  If you have not yet had a chance to forward the survey, I would ask that 
you do so before the survey closes on __________. 
Again, thank you for your help and support.  Please contact me requesting study results if 
you are interested in the outcomes of this study.  Should you have any questions or 
concerns, please do not hesitate to contact me. 
Respectfully, 
Kristin Trainor, MSW, LCSW 
Indiana University School of Social Work 
902 W New York Street ES 4138 
Indianapolis, Indiana 
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Appendix D:  Participant Reminder Letter 
 
Greetings Healthcare Providers, 
This e-mail is a reminder request for your participation in an important research study 
aimed at discovering new information the effects on healthcare providers whom work 
with prenatal substance misuse. The information is important for many reasons. Drug use 
during pregnancy is a public health crisis.  Healthcare providers face highly stressful 
work situations. More needs to be done to support healthcare providers, and exploring the 
attitudes and perceptions of healthcare providers may offer insight to aid those in the 
workforce and the families affected by prenatal substance misuse. In addition, this project 
will provide information that may inform the way healthcare institutions approach 
prenatal substance misuse. This study is called Prenatal Substance Misuse Attitudes and 
Perceptions. This web-based study should take only 15-30 minutes to complete. I would 
appreciate it greatly if you would complete the survey. 
Participation in the study is voluntary and you may stop at any time. You are receiving 
this e-mail through your employer’s listserv. I do not have your personal information and 
will not contact you for further information. I will not know who took the survey and 
who did not.  
If you have any questions about this survey, please contact Kristin Trainor.  In addition, 
more information about the study can be found by reading the study information sheet on 
the first page of the survey. 
If you would like to participate, please click on the following link: 
I look forward to your participation and am thankful for your commitment to the 
healthcare profession.  
Respectfully, 
Kristin Trainor, MSW, LCSW 
Indiana University School of Social Work 
902 W New York Street ES 4138 
Indianapolis, Indiana 
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Appendix E:  Modification Consent 
Kristin Trainor  
 
 
 
 
to e.silins 
 
 
Dear Mr. Silins, 
 
I am doctoral candidate at Indiana University School of Social Work in Indianapolis, 
Indiana, USA.   My research area lies in attitudes of health care providers (across 
disciplines) of prenatal substance misuse. 
 
I am seeking access and permission to use your questionnaire from your study on: The 
influence of structured education and clinical experience on the attitudes of medical 
students towards substance misusers.  The questionnaire may be slightly modified. 
 
If you would like further information regarding the proposed study, I am happy to oblige. 
I appreciate your consideration. 
 
Best regards, 
Kristin Trainor MSW, LCSW 
Doctoral Candidate 
Indiana University School of Social Work 
 
Edmund Silins  
 
Oc
t 8 
 
 
 
  
Hi Kristin. Sorry for the delay in getting back to you on this but I wanted to run your 
request past the CI. You are more than welcome to use the survey or a modified form of 
it, please cite the paper as the source if relevant. 
 
Best of luck with your research! 
 
Cheers, 
 
Ed 
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Appendix F:  Indiana University Study Information Sheet for Research 
 
Prenatal Substance Misuse Attitudes and Perceptions  
About this research 
You are being asked to participate in a research study.  Scientists do research to answer 
important questions which might help change or improve the way we do things in the 
future.  
Taking part in this research study is voluntary 
You may choose not to take part in the study or may choose to leave the study at any 
time.  Deciding not to participate, or deciding to leave the study later, will not result in 
any penalty or loss of benefits to which you are entitled and will not affect your 
relationship with Ascension Health.  
This form will give you information about the study to help you decide whether you want 
to participate.  Please read this form, and ask any questions you have, before agreeing to 
be in the study. 
WHY IS THIS RESEARCH BEING DONE? 
The purpose of this study is to offer insight to aid health care practitioners and the 
families affected by prenatal substance misuse.  
You were selected as a possible participant because of your employment within the 
healthcare field.   
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WHAT WILL HAPPEN DURING THE STUDY? 
The study is being conducted by Kristin Trainor, Indiana University School of Social 
Work. 
If you agree to be in the study, you will complete a 10-15 minute web-based survey. You 
may end the survey at any time.  There is limited potential harm to participate.  However, 
you may have the potential to experience negative or uncomfortable thoughts associated 
with subject materials.  There is limited risk of loss of confidentiality as the researcher 
will not have your personal information. 
HOW WILL MY INFORMATION BE PROTECTED? 
Efforts will be made to keep your personal information confidential.  We cannot 
guarantee absolute confidentiality.  Your personal information may be disclosed if 
required by law.  No information which could identify you will be shared in publications 
about this study.  Organizations that may inspect and/or copy your research records for 
quality assurance and data analysis include groups such as the study investigator and 
his/her research associates, the Indiana University Institutional Review Board or its 
designees and the Office for Human Research Protections (OHRP), who may need to 
access the research records. 
WILL I BE PAID TO PARTICIPATE?  
Upon completion of the survey you will have the opportunity to participate in a drawing 
to win a $10 Amazon gift card.  One (1) participant per every 250 participants in the 
drawing will be randomly selected for the $10 Amazon gift card.  After completing the 
survey, if you choose to enter the drawing, you will be taken to a new survey to enter 
ONLY your contact information of name and e-mail address. Your name will not be 
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linked to your survey answers as it will be entered into a new domain for the drawing 
opportunity. The drawing is OPTIONAL. 
WHO SHOULD I CALL WITH QUESTIONS OR PROBLEMS? 
For questions about the study or a research-related injury, contact the researcher, Kristin 
Trainor.  If you cannot reach the researcher, please contact the IU Human Subjects Office 
at 800-696-2949 or at irb@iu.edu 
For questions about your rights as a research participant, to discuss problems, complaints, 
or concerns about a research study, or to obtain information or to offer input, please 
contact the IU Human Subjects Office at 800-696-2949 or at irb@iu.edu. 
CAN I WITHDRAW FROM THE STUDY? 
If you decide to participate in this study, you can change your mind and decide to leave 
the study at any time in the future.  The study team will help you withdraw from the 
study safely.  If you decide to withdraw, you may simply stop taking the survey.  
Incomplete surveys will be terminated. 
o I understand and choose to continue. 
o I DO NOT choose to continue.  
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Prenatal Substance Misuse Attitudes and Perceptions Tool 
This survey is intended to elicit your responses to questions related to basic demographic 
information and attitudes towards drug use in pregnancy.  Your participation is greatly 
appreciated. 
A. BACKGROUND INFORMATION 
Please check the most accurate response. 
1. I currently practice in a maternal, fetal, or pediatric setting? 
_____Yes _____ No 
 
2. I hold the following degree/licensure:  Please check the highest level of degree 
attained. 
High School:   Diploma  GED 
College:   Associates   B.A./B.S.  B.S.W. (Social Work) 
Masters:  MSW   MBA   MPH  MHA 
Nursing:  L.P.N   R.N.   B.S.N.   N.P. 
 
Physicians:   M.D.    D.O.  
    Advanced training: 
     OB/GYN   Neonatology    Other 
 
Other:    Physical Therapist (P.T.)  
 Occupational Therapist(OTR/L) 
     Pharmacist (Pharm D)  
   Registered Dietician (RD) 
    Speech/Language Pathologist (SLP) 
    Other (Please specify:    ) 
 
3. My current area of practice is:  Please check the most appropriate response. 
  NICU    PICU   High Risk Obstetrics 
  Pediatrics   CCN   Family Care  
 Outpatient Clinic  Other (specify   ) 
 
4. My current employment role is:  Please check the most appropriate response. 
 Medical Doctor-Direct Care    Medical Doctor-Administration only 
 Direct Care Nurse    Nurse Practitioner 
 Case Manager    Lactation Consultant 
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 Nursing Management    Nursing Educator 
 Social Worker     Pharmacy 
 Child Life     Chaplain 
 Dietary     Radiology/Imaging 
 Language/Interpretive Services  Speech Therapist 
 Respiratory Therapist    Occupational Therapist 
 Physical Therapist    Music Therapist   
 Unit Representative (UR)   Environmental Services 
 Administration    Other (Specify:  
 ) 
 
5. In my current position, I spend the following percentage of my work week in 
direct contact (face to face or on the phone) with maternal/fetal or pediatric clients with 
pregnancy drug use or exposure: 
_____ 0 – 25%  _____ 26 – 50% _____ 51 – 75%     _____ 76 – 100% 
 
6. My current position is: 
_____ Full-time  _____ Part-time  
_____ Other (Please specify ____________________________________________) 
 
7. My race is: 
_____ American Indian or Alaska Native  _____ Black or African American  
_____ Native Hawaiian or Other Pacific Islander _____ Asian  _____ White 
_____ Multi-racial _____ Other (Please specify______________________________) 
 
8. My ethnicity is: 
_____ Hispanic or Latino _____ Not Hispanic or Latino  
 
9. I identify as: 
_____ Female _____ Male  ____ Other  
 
Please provide the most appropriate response. 
10. My age is:  
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11. I have practiced in the health care field for:  
      0-4 years           5-9 years           10-14 years           15-19 years          20-24 years 
      25+years  
 
12. I currently work with mothers with substance misuse or their affected baby. 
_____ yes _____no 
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B. Drug Use in Pregnancy 
 
Please mark the circle that most accurately represents your 
response. 
S
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1. In general, I find it hard to like pregnant cigarette smokers. ○ ○ ○ ○ ○ 
2. I am uncomfortable working with pregnant cigarette smokers. ○ ○ ○ ○ ○ 
3. In general, I find it hard to like pregnant heroin users. ○ ○ ○ ○ ○ 
4. I am uncomfortable working with pregnant heroin users. ○ ○ ○ ○ ○ 
5. In general, I find it hard to like pregnant cocaine users. ○ ○ ○ ○ ○ 
6. I am uncomfortable working with pregnant cocaine users. ○ ○ ○ ○ ○ 
7. In general, I find it hard to like pregnant marijuana users. ○ ○ ○ ○ ○ 
8. I am uncomfortable working with pregnant marijuana users. ○ ○ ○ ○ ○ 
9. In general, I find it hard to like pregnant methamphetamine 
users. 
○ ○ ○ ○ ○ 
10. I am uncomfortable working with pregnant methamphetamine 
users. 
○ ○ ○ ○ ○ 
11. In general, I find it hard to like pregnant opioid users. ○ ○ ○ ○ ○ 
13. I am uncomfortable working with pregnant opioid users. ○ ○ ○ ○ ○ 
14. In general, I find it hard to like pregnant 
subxone/subutex/methadone/ buphernorphine users. 
○ ○ ○ ○ ○ 
15. I am uncomfortable working with pregnant 
subxone/subutex/methadone/buphernorphine users. 
○ ○ ○ ○ ○ 
  
Employment Support 
     
16. My schooling has prepared me to discuss health risk behaviors 
with patients. 
○ ○ ○ ○ ○ 
17. I receive adequate education and training, on the job, for my 
current position. 
○ ○ ○ ○ ○ 
18. I am satisfied with the level of professional supervision I 
receive in my current position. 
○ ○ ○ ○ ○ 
19. I am satisfied with the level of communication between 
disciplines (social workers, nursing, doctors, etc). 
○ ○ ○ ○ ○ 
20. My organization provides a supportive environment for mothers 
with prenatal substance abuse within the organization by having 
and promoting workplace policies that address issues of women 
and infants with substance abuse/exposure. 
○ ○ ○ ○ ○ 
  
Drug Use Outcomes 
     
21. I am satisfied with the level of community support for pregnant 
addicts. 
○ ○ ○ ○ ○ 
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Thank you for your participation.  Your responses are greatly appreciated.  
22. I am comfortable with the discharge plan for a mother with 
addiction. 
○ ○ ○ ○ ○ 
23. I am comfortable with the discharge plan for a child with drug 
exposure. 
○ ○ ○ ○ ○ 
24. I believe more punitive measures should be taken against a 
mother with pregnancy drug misuse. 
○ ○ ○ ○ ○ 
25. I believe hospital staff can provide better, non-medical care for 
a drug exposed infant than the mother 
     
26. I believe mothers with pregnancy drug use should place the 
child for adoption. 
○ ○ ○ ○ ○ 
27. I have become burned out working with mothers and babies 
with drug use/exposure. 
○ ○ ○ ○ ○ 
28. I believe addiction is a medical condition. ○ ○ ○ ○ ○ 
29. I believe addiction is caused by a moral flaw. ○ ○ ○ ○ ○ 
30. I believe addiction is selfish. ○ ○ ○ ○ ○ 
31. I believe a person could quit illicit drug use if they really 
wanted to. 
○ ○ ○ ○ ○ 
32. I believe a person who uses illicit drugs during pregnancy cares 
more about drugs than the baby. 
○ ○ ○ ○ ○ 
33. I believe women who use illicit drugs during pregnancy deserve 
less privacy. 
○ ○ ○ ○ ○ 
34. I have empathy for a pregnant/post-partum woman with 
addiction. 
○ ○ ○ ○ ○ 
35. I believe a drug exposed infant should never discharge with the 
mother. 
○ ○ ○ ○ ○ 
36. I believe a mother with illicit drug use should be regularly drug 
tested. 
○ ○ ○ ○ ○ 
37. I am not comfortable leaving a child in a room with their 
addicted parent. 
○ ○ ○ ○ ○ 
38. I believe the hospital should impose greater sanctions on a 
mother with illicit drug use during pregnancy. 
○ ○ ○ ○ ○ 
39. I believe the state should impose greater sanctions on a mother 
with drug use during pregnancy. 
○ ○ ○ ○ ○ 
40. I would go out of my way to work with a mother or baby with 
drug use/exposure. 
○ ○ ○ ○ ○ 
41. I prefer not to work with babies with drug exposure. ○ ○ ○ ○ ○ 
42. I prefer not to work with pregnant women with addictions. ○ ○ ○ ○ ○ 
43. Lastly, what other information would you like this researcher to 
know about prenatal substance misuse or the effects on health 
care providers. 
None:         
Response  
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